Background  ||| S:24 E:43 ||| NNP
Subcellular  ||| S:43 E:55 ||| NNP
localization  ||| S:55 E:68 ||| NN
of  ||| S:68 E:71 ||| IN
mRNAs  ||| S:71 E:77 ||| NNP
represents  ||| S:77 E:88 ||| VBZ
a  ||| S:88 E:98 ||| DT
fundamental  ||| S:98 E:110 ||| JJ
mechanism  ||| S:110 E:120 ||| NN
for  ||| S:120 E:124 ||| IN
post-transcriptional  ||| S:124 E:145 ||| JJ
control  ||| S:145 E:153 ||| NN
of  ||| S:153 E:164 ||| IN
cell  ||| S:164 E:169 ||| NN
and  ||| S:169 E:173 ||| CC
tissue  ||| S:173 E:180 ||| NN
function ||| S:180 E:188 ||| NN
.  ||| S:188 E:190 ||| .
Examples  ||| S:190 E:199 ||| NNS
include  ||| S:199 E:207 ||| VBP
the  ||| S:207 E:211 ||| DT
polarized  ||| S:211 E:229 ||| JJ
localization  ||| S:229 E:242 ||| NN
of  ||| S:242 E:245 ||| IN
oocyte  ||| S:245 E:252 ||| JJ
mRNAs  ||| S:252 E:258 ||| NN
which  ||| S:258 E:264 ||| WDT
is  ||| S:264 E:267 ||| VBZ
crucial  ||| S:267 E:275 ||| JJ
for  ||| S:275 E:279 ||| IN
the  ||| S:279 E:291 ||| DT
establishment  ||| S:291 E:305 ||| NN
axis  ||| S:305 E:310 ||| NN
formation  ||| S:310 E:320 ||| NN
in  ||| S:320 E:323 ||| IN
the  ||| S:323 E:327 ||| DT
embryo  ||| S:327 E:334 ||| NN
[  ||| S:334 E:336 ||| -LRB-
1  ||| S:336 E:338 ||| CD
2  ||| S:338 E:340 ||| CD
3  ||| S:340 E:342 ||| CD
]  ||| S:342 E:344 ||| -RRB-
,  ||| S:344 E:346 ||| ,
the  ||| S:346 E:358 ||| DT
targeting  ||| S:358 E:368 ||| VBG
of  ||| S:368 E:371 ||| IN
specific  ||| S:371 E:380 ||| JJ
mRNAs  ||| S:380 E:386 ||| JJ
to  ||| S:386 E:389 ||| TO
the  ||| S:389 E:393 ||| DT
synapses  ||| S:393 E:402 ||| NN
of  ||| S:402 E:405 ||| IN
nerve  ||| S:405 E:411 ||| NN
cells  ||| S:411 E:425 ||| NNS
[  ||| S:425 E:427 ||| -LRB-
4  ||| S:427 E:429 ||| CD
5  ||| S:429 E:431 ||| CD
]  ||| S:431 E:433 ||| -RRB-
,  ||| S:433 E:435 ||| ,
centrosomal  ||| S:435 E:447 ||| JJ
segregation  ||| S:447 E:459 ||| NN
of  ||| S:459 E:462 ||| IN
mRNAs  ||| S:462 E:468 ||| JJ
in  ||| S:468 E:471 ||| IN
the  ||| S:471 E:475 ||| DT
mollusk  ||| S:475 E:491 ||| JJ
embryo  ||| S:491 E:498 ||| NN
which  ||| S:498 E:504 ||| WDT
results  ||| S:504 E:512 ||| NNS
in  ||| S:512 E:515 ||| IN
asymmetric  ||| S:515 E:526 ||| JJ
inheritance  ||| S:526 E:538 ||| NN
[  ||| S:538 E:540 ||| -LRB-
6  ||| S:540 E:542 ||| CD
]  ||| S:542 E:544 ||| -RRB-
and  ||| S:544 E:556 ||| CC
the  ||| S:556 E:560 ||| DT
localization  ||| S:560 E:573 ||| NN
of  ||| S:573 E:576 ||| IN
β-actin  ||| S:576 E:584 ||| JJ
mRNA  ||| S:584 E:589 ||| JJ
to  ||| S:589 E:592 ||| TO
sites  ||| S:592 E:598 ||| NNS
of  ||| S:598 E:601 ||| IN
active  ||| S:601 E:608 ||| JJ
actin  ||| S:608 E:622 ||| JJ
polymerization  ||| S:622 E:637 ||| NN
at  ||| S:637 E:640 ||| IN
the  ||| S:640 E:644 ||| DT
leading  ||| S:644 E:652 ||| JJ
edge  ||| S:652 E:657 ||| NN
of  ||| S:657 E:660 ||| IN
motile  ||| S:660 E:667 ||| JJ
fibroblasts  ||| S:667 E:679 ||| NNS
[  ||| S:679 E:689 ||| -LRB-
7  ||| S:689 E:691 ||| CD
8  ||| S:691 E:693 ||| CD
]  ||| S:693 E:695 ||| -RRB-
.  ||| S:695 E:697 ||| .
In  ||| S:697 E:700 ||| IN
each  ||| S:700 E:705 ||| DT
of  ||| S:705 E:708 ||| IN
these  ||| S:708 E:714 ||| DT
cases ||| S:714 E:719 ||| NNS
,  ||| S:719 E:721 ||| ,
mRNA  ||| S:721 E:726 ||| JJ
targeting  ||| S:726 E:736 ||| NN
is  ||| S:736 E:739 ||| VBZ
mediated  ||| S:739 E:756 ||| VBN
by  ||| S:756 E:759 ||| IN
the  ||| S:759 E:763 ||| DT
cytoskeleton ||| S:763 E:775 ||| NN
.  ||| S:775 E:777 ||| .
For  ||| S:777 E:781 ||| IN
example ||| S:781 E:788 ||| NN
,  ||| S:788 E:790 ||| ,
growth  ||| S:790 E:797 ||| NN
factor-induced  ||| S:797 E:820 ||| JJ
localization  ||| S:820 E:833 ||| NN
of  ||| S:833 E:836 ||| IN
actin  ||| S:836 E:842 ||| JJ
mRNA  ||| S:842 E:847 ||| JJ
to  ||| S:847 E:850 ||| TO
the  ||| S:850 E:854 ||| DT
leading  ||| S:854 E:862 ||| JJ
edge  ||| S:862 E:867 ||| NN
of  ||| S:867 E:878 ||| IN
fibroblasts  ||| S:878 E:890 ||| NN
is  ||| S:890 E:893 ||| VBZ
a  ||| S:893 E:895 ||| DT
dynamic ||| S:895 E:902 ||| JJ
,  ||| S:902 E:904 ||| ,
regulated  ||| S:904 E:914 ||| VBN
process  ||| S:914 E:922 ||| NN
requiring  ||| S:922 E:940 ||| VBG
actomyosin  ||| S:940 E:951 ||| JJ
interactions  ||| S:951 E:964 ||| NNS
and  ||| S:964 E:968 ||| CC
activation  ||| S:968 E:979 ||| NN
of  ||| S:979 E:982 ||| IN
the  ||| S:982 E:986 ||| DT
RhoGTPase  ||| S:986 E:1004 ||| JJ
pathway ||| S:1004 E:1011 ||| NN
,  ||| S:1011 E:1013 ||| ,
as  ||| S:1013 E:1016 ||| RB
well  ||| S:1016 E:1021 ||| RB
as  ||| S:1021 E:1024 ||| IN
specific  ||| S:1024 E:1033 ||| JJ
signal  ||| S:1033 E:1040 ||| NN
sequences  ||| S:1040 E:1050 ||| NN
in  ||| S:1050 E:1053 ||| IN
the  ||| S:1053 E:1057 ||| DT
3 ||| S:1057 E:1058 ||| CD
'  ||| S:1058 E:1060 ||| POS
UTR  ||| S:1060 E:1072 ||| NNP
of  ||| S:1072 E:1075 ||| IN
the  ||| S:1075 E:1079 ||| DT
message  ||| S:1079 E:1087 ||| NN
[  ||| S:1087 E:1089 ||| -LRB-
9  ||| S:1089 E:1091 ||| CD
10  ||| S:1091 E:1094 ||| CD
11  ||| S:1094 E:1097 ||| CD
12  ||| S:1097 E:1100 ||| CD
]  ||| S:1100 E:1102 ||| -RRB-
.  ||| S:1102 E:1104 ||| .
Moreover ||| S:1104 E:1112 ||| RB
,  ||| S:1112 E:1114 ||| ,
disruption  ||| S:1114 E:1125 ||| NN
of  ||| S:1125 E:1128 ||| IN
the  ||| S:1128 E:1140 ||| DT
actin  ||| S:1140 E:1146 ||| JJ
cytoskeleton  ||| S:1146 E:1159 ||| NNS
using  ||| S:1159 E:1165 ||| VBG
pharmacological  ||| S:1165 E:1181 ||| JJ
agents  ||| S:1181 E:1188 ||| NNS
also  ||| S:1188 E:1193 ||| RB
blocks  ||| S:1193 E:1208 ||| VBZ
the  ||| S:1208 E:1212 ||| DT
association  ||| S:1212 E:1224 ||| NN
of  ||| S:1224 E:1227 ||| IN
β-actin  ||| S:1227 E:1235 ||| JJ
mRNA  ||| S:1235 E:1240 ||| NN
with  ||| S:1240 E:1245 ||| IN
microfilaments  ||| S:1245 E:1260 ||| NN
and  ||| S:1260 E:1272 ||| CC
prevents  ||| S:1272 E:1281 ||| VBZ
localization  ||| S:1281 E:1294 ||| VBN
of  ||| S:1294 E:1297 ||| IN
the  ||| S:1297 E:1301 ||| DT
transcript  ||| S:1301 E:1312 ||| NN
to  ||| S:1312 E:1315 ||| TO
the  ||| S:1315 E:1319 ||| DT
cell  ||| S:1319 E:1332 ||| NN
periphery  ||| S:1332 E:1342 ||| NN
[  ||| S:1342 E:1344 ||| -LRB-
7  ||| S:1344 E:1346 ||| CD
13  ||| S:1346 E:1349 ||| CD
]  ||| S:1349 E:1351 ||| -RRB-
.  ||| S:1351 E:1353 ||| .
Mechanical  ||| S:1353 E:1364 ||| JJ
forces  ||| S:1364 E:1371 ||| NNS
exerted  ||| S:1371 E:1379 ||| VBN
on  ||| S:1379 E:1382 ||| IN
cell  ||| S:1382 E:1395 ||| NN
surface  ||| S:1395 E:1403 ||| NN
integrin  ||| S:1403 E:1412 ||| NN
receptors ||| S:1412 E:1421 ||| NNS
,  ||| S:1421 E:1423 ||| ,
which  ||| S:1423 E:1429 ||| WDT
anchor  ||| S:1429 E:1436 ||| VBP
the  ||| S:1436 E:1440 ||| DT
actin  ||| S:1440 E:1454 ||| JJ
cytoskeleton  ||| S:1454 E:1467 ||| NN
to  ||| S:1467 E:1470 ||| TO
the  ||| S:1470 E:1474 ||| DT
extracellular  ||| S:1474 E:1488 ||| JJ
matrix ||| S:1488 E:1494 ||| NN
,  ||| S:1494 E:1496 ||| ,
also  ||| S:1496 E:1501 ||| RB
produce  ||| S:1501 E:1517 ||| VB
changes  ||| S:1517 E:1525 ||| NNS
in  ||| S:1525 E:1528 ||| IN
the  ||| S:1528 E:1532 ||| DT
localization  ||| S:1532 E:1545 ||| NN
of  ||| S:1545 E:1548 ||| IN
poly ||| S:1548 E:1552 ||| NNS
( ||| S:1552 E:1553 ||| -LRB-
A ||| S:1553 E:1554 ||| NNP
)  ||| S:1554 E:1556 ||| -RRB-
mRNA  ||| S:1556 E:1561 ||| JJ
and  ||| S:1561 E:1565 ||| CC
ribosomal  ||| S:1565 E:1583 ||| JJ
proteins  ||| S:1583 E:1592 ||| NNS
inside  ||| S:1592 E:1599 ||| IN
the  ||| S:1599 E:1603 ||| DT
cell  ||| S:1603 E:1608 ||| NN
[  ||| S:1608 E:1610 ||| -LRB-
14  ||| S:1610 E:1613 ||| CD
]  ||| S:1613 E:1615 ||| -RRB-
.  ||| S:1615 E:1617 ||| .
Importantly ||| S:1617 E:1628 ||| RB
,  ||| S:1628 E:1630 ||| ,
the  ||| S:1630 E:1642 ||| DT
localization  ||| S:1642 E:1655 ||| NN
of  ||| S:1655 E:1658 ||| IN
transcripts  ||| S:1658 E:1670 ||| NNS
can  ||| S:1670 E:1674 ||| MD
serve  ||| S:1674 E:1680 ||| VB
as  ||| S:1680 E:1683 ||| IN
a  ||| S:1683 E:1685 ||| DT
key  ||| S:1685 E:1689 ||| JJ
regulatory  ||| S:1689 E:1708 ||| JJ
step  ||| S:1708 E:1713 ||| NN
in  ||| S:1713 E:1716 ||| IN
gene  ||| S:1716 E:1721 ||| NN
expression  ||| S:1721 E:1732 ||| NN
as  ||| S:1732 E:1735 ||| IN
inhibition  ||| S:1735 E:1746 ||| NN
of  ||| S:1746 E:1749 ||| IN
mRNA  ||| S:1749 E:1754 ||| JJ
targeting  ||| S:1754 E:1764 ||| NN
can  ||| S:1764 E:1776 ||| MD
significantly  ||| S:1776 E:1790 ||| RB
impact  ||| S:1790 E:1797 ||| NN
cell  ||| S:1797 E:1802 ||| NN
function ||| S:1802 E:1810 ||| NN
.  ||| S:1810 E:1812 ||| .
For  ||| S:1812 E:1816 ||| IN
example ||| S:1816 E:1823 ||| NN
,  ||| S:1823 E:1825 ||| ,
replacing  ||| S:1825 E:1843 ||| VBG
the  ||| S:1843 E:1847 ||| DT
3 ||| S:1847 E:1848 ||| CD
'  ||| S:1848 E:1850 ||| POS
UTR  ||| S:1850 E:1854 ||| NNP
of  ||| S:1854 E:1857 ||| IN
the  ||| S:1857 E:1861 ||| DT
mRNA  ||| S:1861 E:1866 ||| JJ
for  ||| S:1866 E:1870 ||| IN
the  ||| S:1870 E:1874 ||| DT
intermediate  ||| S:1874 E:1887 ||| JJ
filament  ||| S:1887 E:1904 ||| JJ
protein ||| S:1904 E:1911 ||| NN
,  ||| S:1911 E:1913 ||| ,
vimentin ||| S:1913 E:1921 ||| NN
,  ||| S:1921 E:1923 ||| ,
with  ||| S:1923 E:1928 ||| IN
the  ||| S:1928 E:1932 ||| DT
β-actin  ||| S:1932 E:1940 ||| JJ
3 ||| S:1940 E:1941 ||| CD
' ||| S:1941 E:1942 ||| POS
UTR  ||| S:1942 E:1946 ||| NNP
sequence  ||| S:1946 E:1955 ||| NN
results  ||| S:1955 E:1971 ||| NNS
in  ||| S:1971 E:1974 ||| IN
mislocalization  ||| S:1974 E:1990 ||| NN
of  ||| S:1990 E:1993 ||| IN
vimentin  ||| S:1993 E:2002 ||| JJ
transcript ||| S:2002 E:2012 ||| NN
,  ||| S:2012 E:2014 ||| ,
altered  ||| S:2014 E:2030 ||| VBN
fibroblast  ||| S:2030 E:2041 ||| JJ
morphology ||| S:2041 E:2051 ||| NN
,  ||| S:2051 E:2053 ||| ,
and  ||| S:2053 E:2057 ||| CC
impaired  ||| S:2057 E:2066 ||| JJ
motility  ||| S:2066 E:2075 ||| NNS
[  ||| S:2075 E:2077 ||| -LRB-
15  ||| S:2077 E:2080 ||| CD
]  ||| S:2080 E:2082 ||| -RRB-
.  ||| S:2082 E:2092 ||| .
To  ||| S:2092 E:2095 ||| TO
date ||| S:2095 E:2099 ||| NN
,  ||| S:2099 E:2101 ||| ,
only  ||| S:2101 E:2106 ||| RB
a  ||| S:2106 E:2108 ||| DT
relatively  ||| S:2108 E:2119 ||| RB
small  ||| S:2119 E:2125 ||| JJ
number  ||| S:2125 E:2132 ||| NN
of  ||| S:2132 E:2135 ||| IN
gene  ||| S:2135 E:2148 ||| NN
transcripts  ||| S:2148 E:2160 ||| NNS
are  ||| S:2160 E:2164 ||| VBP
known  ||| S:2164 E:2170 ||| VBN
to  ||| S:2170 E:2173 ||| TO
target  ||| S:2173 E:2180 ||| VB
to  ||| S:2180 E:2183 ||| TO
the  ||| S:2183 E:2187 ||| DT
cytoskeleton  ||| S:2187 E:2200 ||| NN
and  ||| S:2200 E:2204 ||| CC
all  ||| S:2204 E:2216 ||| DT
of  ||| S:2216 E:2219 ||| IN
these  ||| S:2219 E:2225 ||| DT
have  ||| S:2225 E:2230 ||| VBP
been  ||| S:2230 E:2235 ||| VBN
found  ||| S:2235 E:2241 ||| VBN
empirically ||| S:2241 E:2252 ||| NN
.  ||| S:2252 E:2263 ||| .
In  ||| S:2263 E:2266 ||| IN
situ  ||| S:2266 E:2271 ||| JJ
hybridization  ||| S:2271 E:2285 ||| JJ
technologies  ||| S:2285 E:2306 ||| NNS
and  ||| S:2306 E:2310 ||| CC
microinjection  ||| S:2310 E:2325 ||| NN
of  ||| S:2325 E:2328 ||| IN
fluorescently  ||| S:2328 E:2342 ||| JJ
labeled  ||| S:2342 E:2350 ||| JJ
RNAs  ||| S:2350 E:2355 ||| NNS
have  ||| S:2355 E:2368 ||| VBP
greatly  ||| S:2368 E:2376 ||| RB
enhanced  ||| S:2376 E:2385 ||| VBN
our  ||| S:2385 E:2389 ||| PRP$
ability  ||| S:2389 E:2397 ||| NN
to  ||| S:2397 E:2400 ||| TO
observe  ||| S:2400 E:2408 ||| VB
intracellular  ||| S:2408 E:2422 ||| JJ
RNA  ||| S:2422 E:2434 ||| NNP
localization  ||| S:2434 E:2447 ||| NN
with  ||| S:2447 E:2452 ||| IN
high  ||| S:2452 E:2457 ||| JJ
spatial  ||| S:2457 E:2465 ||| JJ
resolution ||| S:2465 E:2475 ||| NN
.  ||| S:2475 E:2477 ||| .
However ||| S:2477 E:2484 ||| RB
,  ||| S:2484 E:2486 ||| ,
the  ||| S:2486 E:2498 ||| DT
number  ||| S:2498 E:2505 ||| NN
of  ||| S:2505 E:2508 ||| IN
RNA  ||| S:2508 E:2512 ||| NNP
species  ||| S:2512 E:2520 ||| NNS
that  ||| S:2520 E:2525 ||| WDT
may  ||| S:2525 E:2529 ||| MD
be  ||| S:2529 E:2532 ||| VB
simultaneously  ||| S:2532 E:2547 ||| RB
observed  ||| S:2547 E:2564 ||| VBD
using  ||| S:2564 E:2570 ||| VBG
these  ||| S:2570 E:2576 ||| DT
approaches  ||| S:2576 E:2587 ||| NN
is  ||| S:2587 E:2590 ||| VBZ
usually  ||| S:2590 E:2598 ||| RB
limited  ||| S:2598 E:2606 ||| VBN
to  ||| S:2606 E:2609 ||| TO
only  ||| S:2609 E:2614 ||| RB
one  ||| S:2614 E:2626 ||| CD
transcript  ||| S:2626 E:2637 ||| NN
at  ||| S:2637 E:2640 ||| IN
a  ||| S:2640 E:2642 ||| DT
time ||| S:2642 E:2646 ||| NN
.  ||| S:2646 E:2648 ||| .
We  ||| S:2648 E:2651 ||| PRP
hypothesized  ||| S:2651 E:2664 ||| VBD
that  ||| S:2664 E:2669 ||| DT
association  ||| S:2669 E:2681 ||| NN
of  ||| S:2681 E:2692 ||| IN
mRNAs  ||| S:2692 E:2698 ||| JJ
with  ||| S:2698 E:2703 ||| IN
the  ||| S:2703 E:2707 ||| DT
cytoskeleton  ||| S:2707 E:2720 ||| NN
may  ||| S:2720 E:2724 ||| MD
be  ||| S:2724 E:2727 ||| VB
a  ||| S:2727 E:2729 ||| DT
more  ||| S:2729 E:2734 ||| RBR
widespread  ||| S:2734 E:2753 ||| JJ
post-transcriptional  ||| S:2753 E:2774 ||| JJ
regulatory  ||| S:2774 E:2785 ||| JJ
mechanism  ||| S:2785 E:2795 ||| NN
that  ||| S:2795 E:2800 ||| WDT
extends  ||| S:2800 E:2808 ||| VBZ
to  ||| S:2808 E:2811 ||| TO
a  ||| S:2811 E:2821 ||| DT
larger  ||| S:2821 E:2828 ||| JJR
subset  ||| S:2828 E:2835 ||| NN
of  ||| S:2835 E:2838 ||| IN
transcripts  ||| S:2838 E:2850 ||| NNS
than  ||| S:2850 E:2855 ||| IN
is  ||| S:2855 E:2858 ||| VBZ
currently  ||| S:2858 E:2868 ||| RB
recognized ||| S:2868 E:2878 ||| VBN
.  ||| S:2878 E:2888 ||| .
To  ||| S:2888 E:2891 ||| TO
explore  ||| S:2891 E:2899 ||| VB
this  ||| S:2899 E:2904 ||| DT
possibility ||| S:2904 E:2915 ||| NN
,  ||| S:2915 E:2917 ||| ,
we  ||| S:2917 E:2920 ||| PRP
used  ||| S:2920 E:2925 ||| VBD
gene  ||| S:2925 E:2930 ||| NN
microarray  ||| S:2930 E:2949 ||| NN
technology  ||| S:2949 E:2960 ||| NN
to  ||| S:2960 E:2963 ||| TO
identify  ||| S:2963 E:2972 ||| VB
and  ||| S:2972 E:2976 ||| CC
analyze  ||| S:2976 E:2984 ||| VB
large  ||| S:2984 E:2990 ||| JJ
populations  ||| S:2990 E:3002 ||| NNS
of  ||| S:3002 E:3013 ||| IN
cytosolic  ||| S:3013 E:3023 ||| NN
and  ||| S:3023 E:3027 ||| CC
cytoskeleton-associated  ||| S:3027 E:3051 ||| JJ
mRNAs  ||| S:3051 E:3057 ||| JJ
isolated  ||| S:3057 E:3066 ||| NN
from  ||| S:3066 E:3079 ||| IN
HL-60  ||| S:3079 E:3085 ||| CD
promyelocytic  ||| S:3085 E:3099 ||| CD
cells ||| S:3099 E:3104 ||| NNS
.  ||| S:3104 E:3106 ||| .
By  ||| S:3106 E:3109 ||| IN
combining  ||| S:3109 E:3119 ||| VBG
traditional  ||| S:3119 E:3139 ||| JJ
biochemical  ||| S:3139 E:3151 ||| NNS
subcellular  ||| S:3151 E:3163 ||| VBP
fractionation  ||| S:3163 E:3177 ||| JJ
methods  ||| S:3177 E:3185 ||| NNS
with  ||| S:3185 E:3198 ||| IN
massively-parallel  ||| S:3198 E:3217 ||| JJ
gene  ||| S:3217 E:3222 ||| NN
profiling  ||| S:3222 E:3232 ||| NN
technology ||| S:3232 E:3242 ||| NN
,  ||| S:3242 E:3244 ||| ,
we  ||| S:3244 E:3247 ||| PRP
were  ||| S:3247 E:3252 ||| VBD
able  ||| S:3252 E:3265 ||| JJ
to  ||| S:3265 E:3268 ||| TO
ask  ||| S:3268 E:3272 ||| VB
the  ||| S:3272 E:3276 ||| DT
question ||| S:3276 E:3284 ||| NN
:  ||| S:3284 E:3286 ||| :
how  ||| S:3286 E:3290 ||| WRB
many  ||| S:3290 E:3295 ||| JJ
different  ||| S:3295 E:3305 ||| JJ
eukaryotic  ||| S:3305 E:3316 ||| JJ
mRNAs  ||| S:3316 E:3330 ||| JJ
interact  ||| S:3330 E:3339 ||| NN
with  ||| S:3339 E:3344 ||| IN
the  ||| S:3344 E:3348 ||| DT
cytoskeletal  ||| S:3348 E:3361 ||| JJ
network  ||| S:3361 E:3369 ||| NN
and  ||| S:3369 E:3373 ||| CC
what  ||| S:3373 E:3378 ||| WP
is  ||| S:3378 E:3381 ||| VBZ
their  ||| S:3381 E:3395 ||| PRP$
identity ||| S:3395 E:3403 ||| NN
?  ||| S:3403 E:3427 ||| .
Results  ||| S:3427 E:3443 ||| NNS
To  ||| S:3443 E:3446 ||| TO
investigate  ||| S:3446 E:3458 ||| VB
whether  ||| S:3458 E:3466 ||| IN
multiple  ||| S:3466 E:3475 ||| JJ
mRNAs  ||| S:3475 E:3481 ||| JJ
associate  ||| S:3481 E:3491 ||| NN
with  ||| S:3491 E:3496 ||| IN
the  ||| S:3496 E:3508 ||| DT
cytoskeleton ||| S:3508 E:3520 ||| NN
,  ||| S:3520 E:3522 ||| ,
exponentially  ||| S:3522 E:3536 ||| VBZ
growing  ||| S:3536 E:3544 ||| VBG
HL-60  ||| S:3544 E:3550 ||| CD
promyelocytic  ||| S:3550 E:3572 ||| CD
cells  ||| S:3572 E:3578 ||| NNS
were  ||| S:3578 E:3583 ||| VBD
biochemically  ||| S:3583 E:3597 ||| VBN
extracted  ||| S:3597 E:3607 ||| VBN
to  ||| S:3607 E:3610 ||| TO
obtain  ||| S:3610 E:3617 ||| VB
fractions  ||| S:3617 E:3635 ||| JJ
enriched  ||| S:3635 E:3644 ||| NN
for  ||| S:3644 E:3648 ||| IN
either  ||| S:3648 E:3655 ||| DT
cytoskeleton  ||| S:3655 E:3668 ||| NN
or  ||| S:3668 E:3671 ||| CC
cytosolic  ||| S:3671 E:3681 ||| JJ
components ||| S:3681 E:3691 ||| NNS
.  ||| S:3691 E:3701 ||| .
Briefly ||| S:3701 E:3708 ||| RB
,  ||| S:3708 E:3710 ||| ,
cells  ||| S:3710 E:3716 ||| NNS
were  ||| S:3716 E:3721 ||| VBD
harvested  ||| S:3721 E:3731 ||| VBN
and  ||| S:3731 E:3735 ||| CC
lysed  ||| S:3735 E:3741 ||| NN
in  ||| S:3741 E:3744 ||| IN
nonionic  ||| S:3744 E:3761 ||| JJ
detergent  ||| S:3761 E:3771 ||| NN
to  ||| S:3771 E:3774 ||| TO
release  ||| S:3774 E:3782 ||| VB
the  ||| S:3782 E:3786 ||| DT
soluble ||| S:3786 E:3793 ||| JJ
,  ||| S:3793 E:3795 ||| ,
cytosolic  ||| S:3795 E:3805 ||| JJ
fraction ||| S:3805 E:3813 ||| NN
.  ||| S:3813 E:3815 ||| .
Upon  ||| S:3815 E:3828 ||| IN
centrifugation ||| S:3828 E:3842 ||| NN
,  ||| S:3842 E:3844 ||| ,
the  ||| S:3844 E:3848 ||| DT
pellet ||| S:3848 E:3854 ||| NN
,  ||| S:3854 E:3856 ||| ,
containing  ||| S:3856 E:3867 ||| VBG
cellular  ||| S:3867 E:3876 ||| JJ
matrix ||| S:3876 E:3882 ||| NN
,  ||| S:3882 E:3884 ||| ,
was  ||| S:3884 E:3896 ||| VBD
resuspended  ||| S:3896 E:3908 ||| VBN
in  ||| S:3908 E:3911 ||| IN
high  ||| S:3911 E:3916 ||| JJ
salt  ||| S:3916 E:3921 ||| NN
buffer  ||| S:3921 E:3928 ||| NN
to  ||| S:3928 E:3931 ||| TO
release  ||| S:3931 E:3947 ||| VB
cytoskeleton-associated  ||| S:3947 E:3971 ||| JJ
components ||| S:3971 E:3981 ||| NNS
.  ||| S:3981 E:3983 ||| .
RNA  ||| S:3983 E:3987 ||| NNP
was  ||| S:3987 E:3991 ||| VBD
isolated  ||| S:3991 E:4000 ||| VBN
from  ||| S:4000 E:4013 ||| IN
both  ||| S:4013 E:4018 ||| DT
fractions  ||| S:4018 E:4028 ||| NN
and  ||| S:4028 E:4032 ||| CC
hybridized  ||| S:4032 E:4043 ||| JJ
to  ||| S:4043 E:4046 ||| TO
nylon  ||| S:4046 E:4052 ||| VB
filter  ||| S:4052 E:4059 ||| JJ
DNA  ||| S:4059 E:4063 ||| NN
arrays  ||| S:4063 E:4078 ||| NNS
that  ||| S:4078 E:4083 ||| WDT
contained  ||| S:4083 E:4093 ||| VBD
5184  ||| S:4093 E:4098 ||| CD
gene  ||| S:4098 E:4103 ||| NN
or  ||| S:4103 E:4106 ||| CC
EST  ||| S:4106 E:4110 ||| NNP
sequences ||| S:4110 E:4119 ||| NN
.  ||| S:4119 E:4121 ||| .
After  ||| S:4121 E:4127 ||| IN
filtering  ||| S:4127 E:4145 ||| VBG
out  ||| S:4145 E:4149 ||| RP
genes  ||| S:4149 E:4155 ||| NNS
whose  ||| S:4155 E:4161 ||| WP$
signal  ||| S:4161 E:4168 ||| NN
intensity  ||| S:4168 E:4178 ||| NN
was  ||| S:4178 E:4182 ||| VBD
not  ||| S:4182 E:4186 ||| RB
significantly  ||| S:4186 E:4208 ||| RB
above  ||| S:4208 E:4214 ||| IN
background  ||| S:4214 E:4225 ||| NN
noise ||| S:4225 E:4230 ||| NN
,  ||| S:4230 E:4232 ||| ,
649  ||| S:4232 E:4236 ||| CD
known  ||| S:4236 E:4242 ||| JJ
genes  ||| S:4242 E:4248 ||| NNS
remained ||| S:4248 E:4256 ||| VBD
.  ||| S:4256 E:4258 ||| .
Analysis  ||| S:4258 E:4275 ||| NN
of  ||| S:4275 E:4278 ||| IN
these  ||| S:4278 E:4284 ||| DT
genes  ||| S:4284 E:4290 ||| NNS
revealed  ||| S:4290 E:4299 ||| VBD
a  ||| S:4299 E:4301 ||| DT
subset  ||| S:4301 E:4308 ||| NN
of  ||| S:4308 E:4311 ||| IN
transcripts  ||| S:4311 E:4323 ||| NNS
that  ||| S:4323 E:4328 ||| WDT
were  ||| S:4328 E:4341 ||| VBD
enriched  ||| S:4341 E:4350 ||| CD
2-15  ||| S:4350 E:4355 ||| CD
fold  ||| S:4355 E:4360 ||| NN
in  ||| S:4360 E:4363 ||| IN
the  ||| S:4363 E:4367 ||| DT
cytoskeleton  ||| S:4367 E:4380 ||| JJ
fraction  ||| S:4380 E:4389 ||| NN
relative  ||| S:4389 E:4398 ||| JJ
to  ||| S:4398 E:4409 ||| TO
the  ||| S:4409 E:4413 ||| DT
cytosolic  ||| S:4413 E:4423 ||| JJ
fraction  ||| S:4423 E:4432 ||| NN
( ||| S:4432 E:4433 ||| -LRB-
Table  ||| S:4433 E:4439 ||| NNP
1 ||| S:4439 E:4440 ||| CD
,  ||| S:4440 E:4442 ||| ,
top ||| S:4442 E:4445 ||| JJ
) ||| S:4445 E:4446 ||| -RRB-
.  ||| S:4446 E:4448 ||| .
Selected  ||| S:4448 E:4457 ||| JJ
transcripts  ||| S:4457 E:4477 ||| NNS
identified  ||| S:4477 E:4488 ||| VBN
by  ||| S:4488 E:4491 ||| IN
microarray  ||| S:4491 E:4502 ||| JJ
analysis ||| S:4502 E:4510 ||| NN
,  ||| S:4510 E:4512 ||| ,
including  ||| S:4512 E:4522 ||| VBG
β-actin ||| S:4522 E:4529 ||| JJ
,  ||| S:4529 E:4539 ||| ,
spectrin  ||| S:4539 E:4548 ||| NN
and  ||| S:4548 E:4552 ||| CC
phosphatidylinositol-4-kinase  ||| S:4552 E:4582 ||| NNP
( ||| S:4582 E:4583 ||| -LRB-
PI4K ||| S:4583 E:4587 ||| NNP
) ||| S:4587 E:4588 ||| -RRB-
,  ||| S:4588 E:4590 ||| ,
were  ||| S:4590 E:4603 ||| VBD
subsequently  ||| S:4603 E:4616 ||| RB
confirmed  ||| S:4616 E:4626 ||| VBN
by  ||| S:4626 E:4629 ||| IN
semi-quantitative  ||| S:4629 E:4647 ||| JJ
RT-PCR  ||| S:4647 E:4654 ||| NN
( ||| S:4654 E:4655 ||| -LRB-
Fig.  ||| S:4655 E:4668 ||| CD
1 ||| S:4668 E:4669 ||| CD
) ||| S:4669 E:4670 ||| -RRB-
.  ||| S:4670 E:4680 ||| .
Among  ||| S:4680 E:4686 ||| IN
the  ||| S:4686 E:4690 ||| DT
subset  ||| S:4690 E:4697 ||| NN
of  ||| S:4697 E:4700 ||| IN
transcripts  ||| S:4700 E:4712 ||| NNS
that  ||| S:4712 E:4717 ||| WDT
were  ||| S:4717 E:4722 ||| VBD
found  ||| S:4722 E:4728 ||| VBN
to  ||| S:4728 E:4731 ||| TO
be  ||| S:4731 E:4742 ||| VB
enriched  ||| S:4742 E:4751 ||| VBN
in  ||| S:4751 E:4754 ||| IN
the  ||| S:4754 E:4758 ||| DT
cytoskeleton  ||| S:4758 E:4771 ||| JJ
fraction  ||| S:4771 E:4780 ||| NN
were  ||| S:4780 E:4785 ||| VBD
several  ||| S:4785 E:4793 ||| JJ
mRNA  ||| S:4793 E:4806 ||| JJ
species ||| S:4806 E:4813 ||| NNS
,  ||| S:4813 E:4815 ||| ,
such  ||| S:4815 E:4820 ||| JJ
as  ||| S:4820 E:4823 ||| IN
those  ||| S:4823 E:4829 ||| DT
encoding  ||| S:4829 E:4838 ||| JJ
β-actin  ||| S:4838 E:4846 ||| JJ
mRNA  ||| S:4846 E:4851 ||| JJ
and  ||| S:4851 E:4855 ||| CC
ribosomal  ||| S:4855 E:4873 ||| JJ
protein  ||| S:4873 E:4881 ||| NN
subunits ||| S:4881 E:4889 ||| NN
,  ||| S:4889 E:4891 ||| ,
that  ||| S:4891 E:4896 ||| WDT
have  ||| S:4896 E:4901 ||| VBP
previously  ||| S:4901 E:4912 ||| RB
been  ||| S:4912 E:4917 ||| VBN
shown  ||| S:4917 E:4923 ||| VBN
to  ||| S:4923 E:4926 ||| TO
be  ||| S:4926 E:4937 ||| VB
cytoskeleton-associated  ||| S:4937 E:4961 ||| JJ
in  ||| S:4961 E:4964 ||| IN
other  ||| S:4964 E:4970 ||| JJ
cell  ||| S:4970 E:4975 ||| NN
types  ||| S:4975 E:4981 ||| NNS
[  ||| S:4981 E:4983 ||| -LRB-
13  ||| S:4983 E:4986 ||| CD
16  ||| S:4986 E:4989 ||| CD
]  ||| S:4989 E:4991 ||| -RRB-
.  ||| S:4991 E:4993 ||| .
In  ||| S:4993 E:5004 ||| IN
addition ||| S:5004 E:5012 ||| NN
,  ||| S:5012 E:5014 ||| ,
we  ||| S:5014 E:5017 ||| PRP
identified  ||| S:5017 E:5028 ||| VBD
approximately  ||| S:5028 E:5042 ||| RB
20  ||| S:5042 E:5045 ||| CD
new  ||| S:5045 E:5049 ||| JJ
members  ||| S:5049 E:5057 ||| NNS
of  ||| S:5057 E:5060 ||| IN
the  ||| S:5060 E:5072 ||| DT
cytoskeleton-associated  ||| S:5072 E:5096 ||| JJ
transcriptome ||| S:5096 E:5109 ||| NN
,  ||| S:5109 E:5111 ||| ,
the  ||| S:5111 E:5115 ||| DT
majority  ||| S:5115 E:5124 ||| NN
of  ||| S:5124 E:5135 ||| IN
which  ||| S:5135 E:5141 ||| WDT
encode  ||| S:5141 E:5148 ||| VBZ
structural  ||| S:5148 E:5159 ||| JJ
proteins  ||| S:5159 E:5168 ||| NNS
known  ||| S:5168 E:5174 ||| VBN
to  ||| S:5174 E:5177 ||| TO
interact  ||| S:5177 E:5186 ||| VB
directly  ||| S:5186 E:5203 ||| RB
with  ||| S:5203 E:5208 ||| IN
cytoskeleton  ||| S:5208 E:5221 ||| JJ
filaments ||| S:5221 E:5230 ||| NN
,  ||| S:5230 E:5232 ||| ,
such  ||| S:5232 E:5237 ||| JJ
as  ||| S:5237 E:5240 ||| IN
spectrin  ||| S:5240 E:5249 ||| NN
and  ||| S:5249 E:5253 ||| CC
protein  ||| S:5253 E:5269 ||| NN
4.1  ||| S:5269 E:5273 ||| CD
( ||| S:5273 E:5274 ||| -LRB-
Table  ||| S:5274 E:5280 ||| NNP
1 ||| S:5280 E:5281 ||| CD
) ||| S:5281 E:5282 ||| -RRB-
.  ||| S:5282 E:5284 ||| .
Spectrin  ||| S:5284 E:5293 ||| NNP
is  ||| S:5293 E:5296 ||| VBZ
an  ||| S:5296 E:5299 ||| DT
integral  ||| S:5299 E:5308 ||| JJ
component  ||| S:5308 E:5318 ||| NN
of  ||| S:5318 E:5321 ||| IN
the  ||| S:5321 E:5333 ||| DT
submembranous  ||| S:5333 E:5347 ||| JJ
cytoskeleton  ||| S:5347 E:5360 ||| NN
that  ||| S:5360 E:5365 ||| WDT
is  ||| S:5365 E:5368 ||| VBZ
required  ||| S:5368 E:5377 ||| VBN
for  ||| S:5377 E:5381 ||| IN
maintenance  ||| S:5381 E:5401 ||| NN
of  ||| S:5401 E:5404 ||| IN
cell  ||| S:5404 E:5409 ||| NN
shape  ||| S:5409 E:5415 ||| NN
and  ||| S:5415 E:5419 ||| CC
mechanical  ||| S:5419 E:5430 ||| JJ
stability  ||| S:5430 E:5440 ||| NN
of  ||| S:5440 E:5443 ||| IN
the  ||| S:5443 E:5447 ||| DT
surface  ||| S:5447 E:5463 ||| NN
membrane ||| S:5463 E:5471 ||| NN
.  ||| S:5471 E:5473 ||| .
Interactions  ||| S:5473 E:5486 ||| NNS
between  ||| S:5486 E:5494 ||| IN
spectrin  ||| S:5494 E:5503 ||| NN
and  ||| S:5503 E:5507 ||| CC
actin  ||| S:5507 E:5513 ||| JJ
filaments  ||| S:5513 E:5531 ||| NNS
are  ||| S:5531 E:5535 ||| VBP
stabilized  ||| S:5535 E:5546 ||| VBN
by  ||| S:5546 E:5549 ||| IN
protein  ||| S:5549 E:5557 ||| CD
4.1  ||| S:5557 E:5561 ||| CD
and  ||| S:5561 E:5565 ||| CC
regulated  ||| S:5565 E:5575 ||| VBN
by  ||| S:5575 E:5578 ||| IN
a  ||| S:5578 E:5580 ||| DT
variety  ||| S:5580 E:5588 ||| NN
of  ||| S:5588 E:5599 ||| IN
accessory  ||| S:5599 E:5609 ||| JJ
proteins  ||| S:5609 E:5618 ||| NNS
[  ||| S:5618 E:5620 ||| -LRB-
17  ||| S:5620 E:5623 ||| CD
]  ||| S:5623 E:5625 ||| -RRB-
.  ||| S:5625 E:5627 ||| .
Protein  ||| S:5627 E:5635 ||| NNP
4.1  ||| S:5635 E:5639 ||| CD
also  ||| S:5639 E:5644 ||| RB
may  ||| S:5644 E:5648 ||| MD
connect  ||| S:5648 E:5664 ||| VB
the  ||| S:5664 E:5668 ||| DT
protein  ||| S:5668 E:5676 ||| NN
translation  ||| S:5676 E:5688 ||| NN
apparatus  ||| S:5688 E:5698 ||| NN
to  ||| S:5698 E:5701 ||| TO
the  ||| S:5701 E:5705 ||| DT
cytoskeleton  ||| S:5705 E:5726 ||| NN
through  ||| S:5726 E:5734 ||| IN
interactions  ||| S:5734 E:5747 ||| NNS
with  ||| S:5747 E:5752 ||| IN
a  ||| S:5752 E:5754 ||| DT
component  ||| S:5754 E:5764 ||| NN
of  ||| S:5764 E:5767 ||| IN
the  ||| S:5767 E:5771 ||| DT
eukaryotic  ||| S:5771 E:5790 ||| JJ
translation  ||| S:5790 E:5802 ||| NN
initiation  ||| S:5802 E:5813 ||| VBD
factor-3  ||| S:5813 E:5822 ||| CD
complex ||| S:5822 E:5829 ||| NN
,  ||| S:5829 E:5831 ||| ,
eIF3-p44  ||| S:5831 E:5840 ||| NNP
[  ||| S:5840 E:5842 ||| -LRB-
18  ||| S:5842 E:5845 ||| CD
]  ||| S:5845 E:5847 ||| -RRB-
.  ||| S:5847 E:5857 ||| .
Interestingly ||| S:5857 E:5870 ||| RB
,  ||| S:5870 E:5872 ||| ,
mRNAs  ||| S:5872 E:5878 ||| JJ
for  ||| S:5878 E:5882 ||| IN
multiple  ||| S:5882 E:5891 ||| JJ
proteins  ||| S:5891 E:5900 ||| NNS
involved  ||| S:5900 E:5909 ||| VBN
in  ||| S:5909 E:5920 ||| IN
translation ||| S:5920 E:5931 ||| NN
,  ||| S:5931 E:5933 ||| ,
such  ||| S:5933 E:5938 ||| JJ
as  ||| S:5938 E:5941 ||| IN
various  ||| S:5941 E:5949 ||| JJ
ribosomal  ||| S:5949 E:5959 ||| JJ
proteins ||| S:5959 E:5967 ||| NNS
,  ||| S:5967 E:5969 ||| ,
were  ||| S:5969 E:5982 ||| VBD
enriched  ||| S:5982 E:5991 ||| VBN
in  ||| S:5991 E:5994 ||| IN
the  ||| S:5994 E:5998 ||| DT
cytoskeleton  ||| S:5998 E:6011 ||| JJ
fraction  ||| S:6011 E:6020 ||| NN
( ||| S:6020 E:6021 ||| -LRB-
Table  ||| S:6021 E:6027 ||| NNP
I ||| S:6027 E:6028 ||| NNP
) ||| S:6028 E:6029 ||| -RRB-
.  ||| S:6029 E:6031 ||| .
Other  ||| S:6031 E:6045 ||| JJ
transcripts  ||| S:6045 E:6057 ||| NNS
found  ||| S:6057 E:6063 ||| VBD
to  ||| S:6063 E:6066 ||| TO
be  ||| S:6066 E:6069 ||| VB
cytoskeleton-associated  ||| S:6069 E:6093 ||| JJ
in  ||| S:6093 E:6096 ||| IN
this  ||| S:6096 E:6109 ||| DT
study  ||| S:6109 E:6115 ||| NN
encode  ||| S:6115 E:6122 ||| NN
PI4K  ||| S:6122 E:6127 ||| NN
which  ||| S:6127 E:6133 ||| WDT
associates  ||| S:6133 E:6144 ||| NNS
with  ||| S:6144 E:6149 ||| IN
the  ||| S:6149 E:6153 ||| DT
cytoskeleton  ||| S:6153 E:6174 ||| JJ
backbone  ||| S:6174 E:6183 ||| NN
of  ||| S:6183 E:6186 ||| IN
the  ||| S:6186 E:6190 ||| DT
focal  ||| S:6190 E:6196 ||| JJ
adhesion  ||| S:6196 E:6205 ||| NNS
[  ||| S:6205 E:6207 ||| -LRB-
19  ||| S:6207 E:6210 ||| CD
]  ||| S:6210 E:6212 ||| -RRB-
as  ||| S:6212 E:6215 ||| IN
well  ||| S:6215 E:6220 ||| RB
as  ||| S:6220 E:6223 ||| IN
thymosin  ||| S:6223 E:6240 ||| CD
β4 ||| S:6240 E:6242 ||| CD
,  ||| S:6242 E:6244 ||| ,
an  ||| S:6244 E:6247 ||| DT
actin  ||| S:6247 E:6253 ||| JJ
monomer  ||| S:6253 E:6261 ||| JJ
sequestering  ||| S:6261 E:6274 ||| JJ
protein  ||| S:6274 E:6282 ||| NN
that  ||| S:6282 E:6287 ||| WDT
also  ||| S:6287 E:6300 ||| RB
contributes  ||| S:6300 E:6312 ||| VBZ
to  ||| S:6312 E:6315 ||| TO
control  ||| S:6315 E:6323 ||| VB
of  ||| S:6323 E:6326 ||| IN
cell  ||| S:6326 E:6331 ||| NN
motility  ||| S:6331 E:6340 ||| NNS
and  ||| S:6340 E:6344 ||| CC
contractility  ||| S:6344 E:6358 ||| NNS
[  ||| S:6358 E:6368 ||| -LRB-
20  ||| S:6368 E:6371 ||| CD
]  ||| S:6371 E:6373 ||| -RRB-
.  ||| S:6373 E:6383 ||| .
To  ||| S:6383 E:6386 ||| TO
determine  ||| S:6386 E:6396 ||| VB
which  ||| S:6396 E:6402 ||| WDT
specific  ||| S:6402 E:6411 ||| JJ
class  ||| S:6411 E:6417 ||| NN
of  ||| S:6417 E:6420 ||| IN
cytoskeleton  ||| S:6420 E:6441 ||| JJ
filaments  ||| S:6441 E:6451 ||| NN
is  ||| S:6451 E:6454 ||| VBZ
required  ||| S:6454 E:6463 ||| VBN
for  ||| S:6463 E:6467 ||| IN
the  ||| S:6467 E:6471 ||| DT
localization  ||| S:6471 E:6484 ||| NN
of  ||| S:6484 E:6487 ||| IN
these  ||| S:6487 E:6493 ||| DT
mRNAs ||| S:6493 E:6498 ||| JJ
,  ||| S:6498 E:6508 ||| ,
cells  ||| S:6508 E:6514 ||| NNS
were  ||| S:6514 E:6519 ||| VBD
treated  ||| S:6519 E:6527 ||| VBN
with  ||| S:6527 E:6532 ||| IN
latrunculin  ||| S:6532 E:6544 ||| JJ
B  ||| S:6544 E:6546 ||| NNP
( ||| S:6546 E:6547 ||| -LRB-
0.1  ||| S:6547 E:6551 ||| CD
μg ||| S:6551 E:6553 ||| CD
/ ||| S:6553 E:6554 ||| CD
ml ||| S:6554 E:6556 ||| CD
)  ||| S:6556 E:6558 ||| -RRB-
for  ||| S:6558 E:6562 ||| IN
30  ||| S:6562 E:6573 ||| CD
min ||| S:6573 E:6576 ||| NNS
.  ||| S:6576 E:6578 ||| .
Latrunculin  ||| S:6578 E:6590 ||| NNP
B  ||| S:6590 E:6592 ||| NNP
depolymerizes  ||| S:6592 E:6606 ||| FW
actin  ||| S:6606 E:6612 ||| FW
microfilaments  ||| S:6612 E:6627 ||| FW
and  ||| S:6627 E:6639 ||| CC
hence  ||| S:6639 E:6645 ||| RB
should  ||| S:6645 E:6652 ||| MD
release  ||| S:6652 E:6660 ||| VB
components  ||| S:6660 E:6671 ||| NNS
that  ||| S:6671 E:6676 ||| WDT
normally  ||| S:6676 E:6685 ||| RB
associate  ||| S:6685 E:6703 ||| JJ
with  ||| S:6703 E:6708 ||| IN
the  ||| S:6708 E:6712 ||| DT
actin  ||| S:6712 E:6718 ||| JJ
cytoskeleton ||| S:6718 E:6730 ||| NN
.  ||| S:6730 E:6732 ||| .
Western  ||| S:6732 E:6740 ||| JJ
blotting  ||| S:6740 E:6749 ||| NN
of  ||| S:6749 E:6752 ||| IN
the  ||| S:6752 E:6764 ||| DT
biochemical  ||| S:6764 E:6776 ||| JJ
fractions  ||| S:6776 E:6786 ||| NNS
prior  ||| S:6786 E:6792 ||| RB
to  ||| S:6792 E:6795 ||| TO
RNA  ||| S:6795 E:6799 ||| NNP
isolation  ||| S:6799 E:6809 ||| NN
confirmed  ||| S:6809 E:6819 ||| VBD
that  ||| S:6819 E:6832 ||| DT
latrunculin  ||| S:6832 E:6844 ||| JJ
B  ||| S:6844 E:6846 ||| NN
treatment  ||| S:6846 E:6856 ||| NN
resulted  ||| S:6856 E:6865 ||| VBD
in  ||| S:6865 E:6868 ||| IN
a  ||| S:6868 E:6870 ||| DT
dramatic  ||| S:6870 E:6879 ||| JJ
decrease  ||| S:6879 E:6888 ||| NN
in  ||| S:6888 E:6899 ||| IN
the  ||| S:6899 E:6903 ||| DT
amount  ||| S:6903 E:6910 ||| NN
of  ||| S:6910 E:6913 ||| IN
β-actin  ||| S:6913 E:6921 ||| JJ
protein  ||| S:6921 E:6929 ||| NN
that  ||| S:6929 E:6934 ||| WDT
was  ||| S:6934 E:6938 ||| VBD
extracted  ||| S:6938 E:6948 ||| VBN
in  ||| S:6948 E:6951 ||| IN
the  ||| S:6951 E:6963 ||| DT
cytoskeleton  ||| S:6963 E:6976 ||| JJ
fraction ||| S:6976 E:6984 ||| NN
.  ||| S:6984 E:6986 ||| .
RT-PCR  ||| S:6986 E:6993 ||| JJ
of  ||| S:6993 E:6996 ||| IN
RNA  ||| S:6996 E:7000 ||| NNP
isolated  ||| S:7000 E:7009 ||| VBD
from  ||| S:7009 E:7014 ||| IN
these  ||| S:7014 E:7028 ||| DT
samples  ||| S:7028 E:7036 ||| NNS
revealed  ||| S:7036 E:7045 ||| VBD
a  ||| S:7045 E:7047 ||| DT
shift  ||| S:7047 E:7053 ||| NN
of  ||| S:7053 E:7056 ||| IN
the  ||| S:7056 E:7060 ||| DT
cytoskeleton-associated  ||| S:7060 E:7092 ||| JJ
transcripts  ||| S:7092 E:7104 ||| NNS
to  ||| S:7104 E:7107 ||| TO
the  ||| S:7107 E:7111 ||| DT
cytosolic  ||| S:7111 E:7121 ||| JJ
fraction  ||| S:7121 E:7130 ||| NN
upon  ||| S:7130 E:7135 ||| IN
exposure  ||| S:7135 E:7144 ||| NN
to  ||| S:7144 E:7155 ||| TO
latrunculin ||| S:7155 E:7166 ||| VB
,  ||| S:7166 E:7168 ||| ,
indicating  ||| S:7168 E:7179 ||| VBG
that  ||| S:7179 E:7184 ||| IN
these  ||| S:7184 E:7190 ||| DT
transcripts  ||| S:7190 E:7202 ||| NNS
had  ||| S:7202 E:7206 ||| VBD
been  ||| S:7206 E:7219 ||| VBN
associated  ||| S:7219 E:7230 ||| VBN
with  ||| S:7230 E:7235 ||| IN
the  ||| S:7235 E:7239 ||| DT
actin  ||| S:7239 E:7245 ||| JJ
cytoskeleton  ||| S:7245 E:7258 ||| NN
in  ||| S:7258 E:7261 ||| IN
intact  ||| S:7261 E:7268 ||| JJ
cells  ||| S:7268 E:7274 ||| NNS
( ||| S:7274 E:7275 ||| -LRB-
Fig  ||| S:7275 E:7287 ||| NNP
2 ||| S:7287 E:7288 ||| CD
) ||| S:7288 E:7289 ||| -RRB-
.  ||| S:7289 E:7291 ||| .
In  ||| S:7291 E:7294 ||| IN
contrast ||| S:7294 E:7302 ||| NN
,  ||| S:7302 E:7304 ||| ,
depolymerizing  ||| S:7304 E:7319 ||| JJ
microtubules  ||| S:7319 E:7332 ||| NN
with  ||| S:7332 E:7345 ||| IN
nocodazole  ||| S:7345 E:7356 ||| NN
did  ||| S:7356 E:7360 ||| VBD
not  ||| S:7360 E:7364 ||| RB
change  ||| S:7364 E:7371 ||| VB
the  ||| S:7371 E:7375 ||| DT
distribution  ||| S:7375 E:7388 ||| NN
of  ||| S:7388 E:7391 ||| IN
these  ||| S:7391 E:7405 ||| DT
transcripts  ||| S:7405 E:7417 ||| NNS
between  ||| S:7417 E:7425 ||| IN
the  ||| S:7425 E:7429 ||| DT
cytosolic  ||| S:7429 E:7439 ||| NN
and  ||| S:7439 E:7443 ||| CC
cytoskeleton  ||| S:7443 E:7464 ||| JJ
fractions  ||| S:7464 E:7474 ||| NNS
( ||| S:7474 E:7475 ||| -LRB-
data  ||| S:7475 E:7480 ||| NNS
not  ||| S:7480 E:7484 ||| RB
shown ||| S:7484 E:7489 ||| VBN
) ||| S:7489 E:7490 ||| -RRB-
.  ||| S:7490 E:7500 ||| .
HL-60  ||| S:7500 E:7506 ||| NNP
promyelocytic  ||| S:7506 E:7520 ||| JJ
leukemia  ||| S:7520 E:7529 ||| NN
cells  ||| S:7529 E:7535 ||| NNS
have  ||| S:7535 E:7540 ||| VBP
been  ||| S:7540 E:7545 ||| VBN
widely  ||| S:7545 E:7552 ||| RB
used  ||| S:7552 E:7565 ||| VBN
as  ||| S:7565 E:7568 ||| IN
a  ||| S:7568 E:7570 ||| DT
model  ||| S:7570 E:7576 ||| NN
system  ||| S:7576 E:7583 ||| NN
for  ||| S:7583 E:7587 ||| IN
the  ||| S:7587 E:7591 ||| DT
study  ||| S:7591 E:7597 ||| NN
of  ||| S:7597 E:7600 ||| IN
hematopoietic  ||| S:7600 E:7622 ||| JJ
differentiation  ||| S:7622 E:7638 ||| NN
because  ||| S:7638 E:7646 ||| IN
they  ||| S:7646 E:7651 ||| PRP
undergo  ||| S:7651 E:7659 ||| VBP
terminal  ||| S:7659 E:7676 ||| JJ
differentiation  ||| S:7676 E:7692 ||| NN
to  ||| S:7692 E:7695 ||| TO
one  ||| S:7695 E:7699 ||| CD
of  ||| S:7699 E:7702 ||| IN
several  ||| S:7702 E:7710 ||| JJ
cell  ||| S:7710 E:7715 ||| NN
types  ||| S:7715 E:7721 ||| NNS
of  ||| S:7721 E:7724 ||| IN
the  ||| S:7724 E:7736 ||| DT
myelo-monocytic  ||| S:7736 E:7752 ||| JJ
lineage  ||| S:7752 E:7760 ||| NN
when  ||| S:7760 E:7765 ||| WRB
stimulated  ||| S:7765 E:7776 ||| VBN
with  ||| S:7776 E:7781 ||| IN
various  ||| S:7781 E:7797 ||| JJ
pharmacological  ||| S:7797 E:7813 ||| JJ
agents  ||| S:7813 E:7820 ||| NNS
[  ||| S:7820 E:7822 ||| -LRB-
21  ||| S:7822 E:7825 ||| CD
]  ||| S:7825 E:7827 ||| -RRB-
.  ||| S:7827 E:7829 ||| .
In  ||| S:7829 E:7832 ||| IN
particular ||| S:7832 E:7842 ||| JJ
,  ||| S:7842 E:7844 ||| ,
induction  ||| S:7844 E:7854 ||| VBG
of  ||| S:7854 E:7865 ||| IN
macrophage  ||| S:7865 E:7876 ||| JJ
differentiation  ||| S:7876 E:7892 ||| NN
by  ||| S:7892 E:7895 ||| IN
treatment  ||| S:7895 E:7905 ||| NN
of  ||| S:7905 E:7908 ||| IN
HL60  ||| S:7908 E:7913 ||| CD
cells  ||| S:7913 E:7919 ||| NNS
with  ||| S:7919 E:7932 ||| IN
TPA  ||| S:7932 E:7936 ||| NNP
is  ||| S:7936 E:7939 ||| VBZ
accompanied  ||| S:7939 E:7951 ||| VBN
by  ||| S:7951 E:7954 ||| IN
dramatic  ||| S:7954 E:7963 ||| JJ
alterations  ||| S:7963 E:7975 ||| NN
in  ||| S:7975 E:7978 ||| IN
cell  ||| S:7978 E:7991 ||| NN
morphology  ||| S:7991 E:8002 ||| NNS
and  ||| S:8002 E:8006 ||| CC
cytoskeleton  ||| S:8006 E:8019 ||| JJ
structure ||| S:8019 E:8028 ||| NN
.  ||| S:8028 E:8030 ||| .
Precursor  ||| S:8030 E:8040 ||| NNP
HL-60  ||| S:8040 E:8054 ||| NNP
cells  ||| S:8054 E:8060 ||| NNS
are  ||| S:8060 E:8064 ||| VBP
spherical  ||| S:8064 E:8074 ||| VBN
and  ||| S:8074 E:8078 ||| CC
grow  ||| S:8078 E:8083 ||| VB
in  ||| S:8083 E:8086 ||| IN
suspension ||| S:8086 E:8096 ||| NN
,  ||| S:8096 E:8098 ||| ,
whereas  ||| S:8098 E:8106 ||| IN
the  ||| S:8106 E:8118 ||| DT
differentiated  ||| S:8118 E:8133 ||| JJ
macrophage-like  ||| S:8133 E:8149 ||| JJ
cells  ||| S:8149 E:8155 ||| NNS
become  ||| S:8155 E:8162 ||| VBP
adherent  ||| S:8162 E:8171 ||| VBN
and  ||| S:8171 E:8183 ||| CC
spread ||| S:8183 E:8189 ||| NN
.  ||| S:8189 E:8191 ||| .
To  ||| S:8191 E:8194 ||| TO
examine  ||| S:8194 E:8202 ||| VB
whether  ||| S:8202 E:8210 ||| IN
differentiation  ||| S:8210 E:8226 ||| NN
and  ||| S:8226 E:8238 ||| CC
reorganization  ||| S:8238 E:8253 ||| NN
of  ||| S:8253 E:8256 ||| IN
the  ||| S:8256 E:8260 ||| DT
cytoskeleton  ||| S:8260 E:8273 ||| NN
produces  ||| S:8273 E:8282 ||| VBZ
changes  ||| S:8282 E:8290 ||| NNS
in  ||| S:8290 E:8293 ||| IN
mRNA  ||| S:8293 E:8306 ||| JJ
distribution ||| S:8306 E:8318 ||| NN
,  ||| S:8318 E:8320 ||| ,
macrophage  ||| S:8320 E:8331 ||| JJ
differentiation  ||| S:8331 E:8347 ||| NN
was  ||| S:8347 E:8351 ||| VBD
induced  ||| S:8351 E:8359 ||| VBN
by  ||| S:8359 E:8362 ||| IN
the  ||| S:8362 E:8374 ||| DT
addition  ||| S:8374 E:8383 ||| NN
of  ||| S:8383 E:8386 ||| IN
10  ||| S:8386 E:8389 ||| CD
nM  ||| S:8389 E:8392 ||| JJ
TPA  ||| S:8392 E:8396 ||| NNP
to  ||| S:8396 E:8399 ||| TO
suspension  ||| S:8399 E:8410 ||| NN
cultures  ||| S:8410 E:8419 ||| NNS
of  ||| S:8419 E:8430 ||| IN
exponentially  ||| S:8430 E:8444 ||| FW
proliferating  ||| S:8444 E:8458 ||| FW
HL-60  ||| S:8458 E:8464 ||| FW
promyelocytic  ||| S:8464 E:8478 ||| FW
cells ||| S:8478 E:8483 ||| NNS
.  ||| S:8483 E:8493 ||| .
Within  ||| S:8493 E:8500 ||| IN
40  ||| S:8500 E:8503 ||| CD
hrs  ||| S:8503 E:8507 ||| NN
of  ||| S:8507 E:8510 ||| IN
induction ||| S:8510 E:8519 ||| NN
,  ||| S:8519 E:8521 ||| ,
the  ||| S:8521 E:8525 ||| DT
previously  ||| S:8525 E:8536 ||| RB
non-adherent  ||| S:8536 E:8557 ||| JJ
cells  ||| S:8557 E:8563 ||| NNS
( ||| S:8563 E:8564 ||| -LRB-
Fig.  ||| S:8564 E:8569 ||| NNP
3A ||| S:8569 E:8571 ||| NNP
)  ||| S:8571 E:8573 ||| -RRB-
attached  ||| S:8573 E:8582 ||| VBN
and  ||| S:8582 E:8586 ||| CC
spread  ||| S:8586 E:8593 ||| NN
on  ||| S:8593 E:8596 ||| IN
the  ||| S:8596 E:8600 ||| DT
tissue  ||| S:8600 E:8607 ||| NN
culture  ||| S:8607 E:8623 ||| NN
plastic  ||| S:8623 E:8631 ||| NN
( ||| S:8631 E:8632 ||| -LRB-
Fig.  ||| S:8632 E:8637 ||| NNP
3B ||| S:8637 E:8639 ||| NNP
) ||| S:8639 E:8640 ||| -RRB-
.  ||| S:8640 E:8642 ||| .
The  ||| S:8642 E:8646 ||| DT
serial  ||| S:8646 E:8653 ||| JJ
extraction  ||| S:8653 E:8664 ||| JJ
approach  ||| S:8664 E:8673 ||| NN
described  ||| S:8673 E:8691 ||| VBD
above  ||| S:8691 E:8697 ||| RB
was  ||| S:8697 E:8701 ||| VBD
used  ||| S:8701 E:8706 ||| VBN
to  ||| S:8706 E:8709 ||| TO
separate  ||| S:8709 E:8718 ||| JJ
cytosolic  ||| S:8718 E:8728 ||| NN
and  ||| S:8728 E:8732 ||| CC
cytoskeleton  ||| S:8732 E:8745 ||| JJ
mRNA  ||| S:8745 E:8758 ||| JJ
fractions  ||| S:8758 E:8768 ||| NNS
from  ||| S:8768 E:8773 ||| IN
these  ||| S:8773 E:8779 ||| DT
adherent  ||| S:8779 E:8788 ||| JJ
cells ||| S:8788 E:8793 ||| NNS
.  ||| S:8793 E:8795 ||| .
Spatial  ||| S:8795 E:8803 ||| JJ
distribution  ||| S:8803 E:8824 ||| NN
profiles  ||| S:8824 E:8833 ||| NNS
of  ||| S:8833 E:8836 ||| IN
mRNAs  ||| S:8836 E:8842 ||| JJ
in  ||| S:8842 E:8845 ||| IN
differentiated  ||| S:8845 E:8860 ||| CD
HL-60  ||| S:8860 E:8866 ||| CD
cells  ||| S:8866 E:8872 ||| NNS
were  ||| S:8872 E:8885 ||| VBD
obtained  ||| S:8885 E:8894 ||| VBN
using  ||| S:8894 E:8900 ||| VBG
microarrays  ||| S:8900 E:8912 ||| NNS
and  ||| S:8912 E:8916 ||| CC
compared  ||| S:8916 E:8925 ||| VBN
with  ||| S:8925 E:8930 ||| IN
profiles  ||| S:8930 E:8939 ||| NNS
of  ||| S:8939 E:8950 ||| IN
the  ||| S:8950 E:8954 ||| DT
spherical  ||| S:8954 E:8964 ||| JJ
precursor  ||| S:8964 E:8974 ||| NN
HL-60  ||| S:8974 E:8980 ||| CD
cells ||| S:8980 E:8985 ||| NNS
.  ||| S:8985 E:8995 ||| .
Rather  ||| S:8995 E:9002 ||| RB
than  ||| S:9002 E:9007 ||| IN
comparing  ||| S:9007 E:9017 ||| VBG
the  ||| S:9017 E:9021 ||| DT
entire  ||| S:9021 E:9028 ||| JJ
transcriptome  ||| S:9028 E:9042 ||| NN
of  ||| S:9042 E:9053 ||| IN
undifferentiated  ||| S:9053 E:9070 ||| FW
versus  ||| S:9070 E:9077 ||| FW
differentiated  ||| S:9077 E:9092 ||| FW
cells  ||| S:9092 E:9098 ||| NNS
as  ||| S:9098 E:9101 ||| RB
is  ||| S:9101 E:9104 ||| VBZ
commonly  ||| S:9104 E:9121 ||| RB
done  ||| S:9121 E:9126 ||| VBN
[  ||| S:9126 E:9128 ||| -LRB-
22  ||| S:9128 E:9131 ||| CD
]  ||| S:9131 E:9133 ||| -RRB-
,  ||| S:9133 E:9135 ||| ,
we  ||| S:9135 E:9138 ||| PRP
were  ||| S:9138 E:9143 ||| VBD
interested  ||| S:9143 E:9154 ||| VBN
in  ||| S:9154 E:9157 ||| IN
how  ||| S:9157 E:9161 ||| WRB
the  ||| S:9161 E:9165 ||| DT
two  ||| S:9165 E:9177 ||| CD
transcriptome  ||| S:9177 E:9191 ||| NNS
compartments  ||| S:9191 E:9204 ||| VBP
behaved  ||| S:9204 E:9212 ||| VBN
upon  ||| S:9212 E:9217 ||| IN
differentiation  ||| S:9217 E:9233 ||| NN
and  ||| S:9233 E:9245 ||| CC
adhesion ||| S:9245 E:9253 ||| NN
.  ||| S:9253 E:9255 ||| .
We  ||| S:9255 E:9258 ||| PRP
found  ||| S:9258 E:9264 ||| VBD
that  ||| S:9264 E:9269 ||| IN
the  ||| S:9269 E:9273 ||| DT
terminally  ||| S:9273 E:9284 ||| JJ
differentiated  ||| S:9284 E:9299 ||| JJ
cells  ||| S:9299 E:9313 ||| NNS
contained  ||| S:9313 E:9323 ||| VBD
a  ||| S:9323 E:9325 ||| DT
greater  ||| S:9325 E:9333 ||| JJR
number  ||| S:9333 E:9340 ||| NN
of  ||| S:9340 E:9343 ||| IN
cytoskeleton-associated  ||| S:9343 E:9375 ||| JJ
transcripts  ||| S:9375 E:9387 ||| NNS
than  ||| S:9387 E:9392 ||| IN
suspended  ||| S:9392 E:9402 ||| VBN
precursor  ||| S:9402 E:9412 ||| JJ
cells ||| S:9412 E:9417 ||| NNS
,  ||| S:9417 E:9419 ||| ,
consistent  ||| S:9419 E:9430 ||| JJ
with  ||| S:9430 E:9443 ||| IN
the  ||| S:9443 E:9447 ||| DT
idea  ||| S:9447 E:9452 ||| NN
that  ||| S:9452 E:9457 ||| IN
the  ||| S:9457 E:9461 ||| DT
cytoskeleton  ||| S:9461 E:9474 ||| NN
plays  ||| S:9474 E:9480 ||| VBZ
a  ||| S:9480 E:9482 ||| DT
larger  ||| S:9482 E:9489 ||| JJR
role  ||| S:9489 E:9494 ||| NN
in  ||| S:9494 E:9505 ||| IN
organizing  ||| S:9505 E:9516 ||| VBG
RNAs  ||| S:9516 E:9521 ||| JJ
in  ||| S:9521 E:9524 ||| IN
adherent  ||| S:9524 E:9533 ||| JJ
cells  ||| S:9533 E:9539 ||| NNS
( ||| S:9539 E:9540 ||| -LRB-
Table  ||| S:9540 E:9546 ||| FW
1bottom  ||| S:9546 E:9554 ||| FW
versus  ||| S:9554 E:9569 ||| FW
top ||| S:9569 E:9572 ||| NN
,  ||| S:9572 E:9574 ||| ,
and  ||| S:9574 E:9578 ||| CC
Fig.  ||| S:9578 E:9583 ||| CD
4 ||| S:9583 E:9584 ||| CD
) ||| S:9584 E:9585 ||| -RRB-
.  ||| S:9585 E:9587 ||| .
Approximately  ||| S:9587 E:9601 ||| RB
22  ||| S:9601 E:9604 ||| CD
unique  ||| S:9604 E:9611 ||| JJ
mRNAs  ||| S:9611 E:9617 ||| JJ
exhibited  ||| S:9617 E:9635 ||| JJ
2-fold  ||| S:9635 E:9642 ||| NN
or  ||| S:9642 E:9645 ||| CC
more  ||| S:9645 E:9650 ||| JJR
enrichment  ||| S:9650 E:9661 ||| NN
in  ||| S:9661 E:9664 ||| IN
the  ||| S:9664 E:9668 ||| DT
cytoskeleton-associated  ||| S:9668 E:9700 ||| JJ
samples ||| S:9700 E:9707 ||| NNS
.  ||| S:9707 E:9709 ||| .
A  ||| S:9709 E:9711 ||| DT
scatterplot  ||| S:9711 E:9723 ||| NN
of  ||| S:9723 E:9726 ||| IN
the  ||| S:9726 E:9730 ||| DT
ratios  ||| S:9730 E:9737 ||| NNS
of  ||| S:9737 E:9740 ||| IN
cytoskeleton  ||| S:9740 E:9753 ||| VBG
to  ||| S:9753 E:9764 ||| TO
cytosolic  ||| S:9764 E:9774 ||| VB
RNAs  ||| S:9774 E:9779 ||| JJ
in  ||| S:9779 E:9782 ||| IN
the  ||| S:9782 E:9786 ||| DT
precursor  ||| S:9786 E:9796 ||| NN
and  ||| S:9796 E:9800 ||| CC
macrophage  ||| S:9800 E:9811 ||| JJ
cells  ||| S:9811 E:9825 ||| NNS
revealed  ||| S:9825 E:9834 ||| VBD
a  ||| S:9834 E:9836 ||| DT
shift  ||| S:9836 E:9842 ||| NN
in  ||| S:9842 E:9845 ||| IN
the  ||| S:9845 E:9849 ||| DT
distribution  ||| S:9849 E:9862 ||| NN
of  ||| S:9862 E:9865 ||| IN
individual  ||| S:9865 E:9884 ||| JJ
transcripts  ||| S:9884 E:9896 ||| NNS
to  ||| S:9896 E:9899 ||| TO
the  ||| S:9899 E:9903 ||| DT
cytoskeletal  ||| S:9903 E:9916 ||| JJ
compartment  ||| S:9916 E:9928 ||| NN
upon  ||| S:9928 E:9941 ||| IN
differentiation  ||| S:9941 E:9957 ||| NNS
( ||| S:9957 E:9958 ||| -LRB-
Fig.  ||| S:9958 E:9963 ||| CD
4 ||| S:9963 E:9964 ||| CD
) ||| S:9964 E:9965 ||| -RRB-
.  ||| S:9965 E:9967 ||| .
However ||| S:9967 E:9974 ||| RB
,  ||| S:9974 E:9976 ||| ,
the  ||| S:9976 E:9980 ||| DT
majority  ||| S:9980 E:9989 ||| NN
of  ||| S:9989 E:10000 ||| IN
transcripts  ||| S:10000 E:10012 ||| NNS
did  ||| S:10012 E:10016 ||| VBD
not  ||| S:10016 E:10020 ||| RB
change  ||| S:10020 E:10027 ||| VB
their  ||| S:10027 E:10033 ||| PRP$
localization  ||| S:10033 E:10046 ||| JJ
status  ||| S:10046 E:10053 ||| NN
as  ||| S:10053 E:10064 ||| IN
indicated  ||| S:10064 E:10074 ||| VBN
by  ||| S:10074 E:10077 ||| IN
the  ||| S:10077 E:10081 ||| DT
fact  ||| S:10081 E:10086 ||| NN
that  ||| S:10086 E:10091 ||| IN
the  ||| S:10091 E:10095 ||| DT
ratios  ||| S:10095 E:10102 ||| NNS
of  ||| S:10102 E:10105 ||| IN
most  ||| S:10105 E:10110 ||| JJS
genes  ||| S:10110 E:10124 ||| NNS
remained  ||| S:10124 E:10133 ||| VBD
close  ||| S:10133 E:10139 ||| RB
to  ||| S:10139 E:10142 ||| TO
the  ||| S:10142 E:10146 ||| DT
diagonal  ||| S:10146 E:10155 ||| NN
in  ||| S:10155 E:10158 ||| IN
this  ||| S:10158 E:10163 ||| DT
plot ||| S:10163 E:10167 ||| NN
.  ||| S:10167 E:10177 ||| .
To  ||| S:10177 E:10180 ||| TO
further  ||| S:10180 E:10188 ||| RBR
characterize  ||| S:10188 E:10201 ||| JJ
changes  ||| S:10201 E:10209 ||| NNS
in  ||| S:10209 E:10212 ||| IN
the  ||| S:10212 E:10216 ||| DT
overall  ||| S:10216 E:10232 ||| JJ
distribution  ||| S:10232 E:10245 ||| NN
pattern  ||| S:10245 E:10253 ||| NN
of  ||| S:10253 E:10256 ||| IN
mRNAs  ||| S:10256 E:10262 ||| JJ
upon  ||| S:10262 E:10267 ||| IN
differentiation ||| S:10267 E:10282 ||| NN
,  ||| S:10282 E:10284 ||| ,
we  ||| S:10284 E:10295 ||| PRP
performed  ||| S:10295 E:10305 ||| VBD
hierarchical  ||| S:10305 E:10318 ||| JJ
cluster  ||| S:10318 E:10326 ||| NN
analysis  ||| S:10326 E:10335 ||| NN
of  ||| S:10335 E:10338 ||| IN
the  ||| S:10338 E:10342 ||| DT
four  ||| S:10342 E:10355 ||| CD
different  ||| S:10355 E:10365 ||| JJ
RNA  ||| S:10365 E:10369 ||| NNP
profiles  ||| S:10369 E:10378 ||| NNS
representing  ||| S:10378 E:10391 ||| VBG
the  ||| S:10391 E:10395 ||| DT
two  ||| S:10395 E:10399 ||| CD
spatial  ||| S:10399 E:10407 ||| CD
pools  ||| S:10407 E:10421 ||| NNS
( ||| S:10421 E:10422 ||| -LRB-
cytosolic  ||| S:10422 E:10432 ||| NN
and  ||| S:10432 E:10436 ||| CC
cytoskeleton ||| S:10436 E:10448 ||| CD
)  ||| S:10448 E:10450 ||| -RRB-
in  ||| S:10450 E:10453 ||| IN
the  ||| S:10453 E:10457 ||| DT
two  ||| S:10457 E:10461 ||| CD
cell  ||| S:10461 E:10466 ||| NN
types  ||| S:10466 E:10480 ||| NNS
( ||| S:10480 E:10481 ||| -LRB-
undifferentiated  ||| S:10481 E:10498 ||| NN
and  ||| S:10498 E:10502 ||| CC
differentiated  ||| S:10502 E:10517 ||| JJ
cells ||| S:10517 E:10522 ||| NNS
) ||| S:10522 E:10523 ||| -RRB-
.  ||| S:10523 E:10525 ||| .
Complete  ||| S:10525 E:10542 ||| JJ
linkage  ||| S:10542 E:10550 ||| NNS
clustering  ||| S:10550 E:10561 ||| VBP
based  ||| S:10561 E:10567 ||| VBN
on  ||| S:10567 E:10570 ||| IN
Euclidean  ||| S:10570 E:10580 ||| NNP
distance  ||| S:10580 E:10589 ||| NN
[  ||| S:10589 E:10591 ||| -LRB-
23  ||| S:10591 E:10594 ||| CD
]  ||| S:10594 E:10596 ||| -RRB-
of  ||| S:10596 E:10607 ||| IN
these  ||| S:10607 E:10613 ||| DT
four  ||| S:10613 E:10618 ||| CD
sets  ||| S:10618 E:10623 ||| NNS
of  ||| S:10623 E:10626 ||| IN
transcripts  ||| S:10626 E:10638 ||| NNS
( ||| S:10638 E:10639 ||| -LRB-
cytosolic  ||| S:10639 E:10649 ||| FW
versus  ||| S:10649 E:10664 ||| FW
cytoskeleton  ||| S:10664 E:10677 ||| FW
transcripts  ||| S:10677 E:10689 ||| FW
in  ||| S:10689 E:10692 ||| IN
HL-60  ||| S:10692 E:10698 ||| CD
cells  ||| S:10698 E:10704 ||| NNS
in  ||| S:10704 E:10707 ||| IN
the  ||| S:10707 E:10711 ||| DT
presence  ||| S:10711 E:10720 ||| NN
or  ||| S:10720 E:10731 ||| CC
absence  ||| S:10731 E:10739 ||| NN
of  ||| S:10739 E:10742 ||| IN
TPA ||| S:10742 E:10745 ||| NNP
)  ||| S:10745 E:10747 ||| -RRB-
revealed  ||| S:10747 E:10756 ||| VBD
that  ||| S:10756 E:10761 ||| IN
the  ||| S:10761 E:10765 ||| DT
cytoskeleton-anchored  ||| S:10765 E:10795 ||| JJ
population  ||| S:10795 E:10806 ||| NN
in  ||| S:10806 E:10809 ||| IN
the  ||| S:10809 E:10813 ||| DT
precursor  ||| S:10813 E:10823 ||| JJ
HL-60  ||| S:10823 E:10829 ||| CD
cells  ||| S:10829 E:10835 ||| NNS
and  ||| S:10835 E:10839 ||| CC
those  ||| S:10839 E:10845 ||| DT
in  ||| S:10845 E:10848 ||| IN
the  ||| S:10848 E:10860 ||| DT
macrophage  ||| S:10860 E:10871 ||| JJ
cells  ||| S:10871 E:10877 ||| NNS
were  ||| S:10877 E:10882 ||| VBD
most  ||| S:10882 E:10887 ||| RBS
similar  ||| S:10887 E:10895 ||| JJ
( ||| S:10895 E:10896 ||| -LRB-
Fig.  ||| S:10896 E:10901 ||| CD
5 ||| S:10901 E:10902 ||| CD
) ||| S:10902 E:10903 ||| -RRB-
.  ||| S:10903 E:10905 ||| .
In  ||| S:10905 E:10908 ||| IN
other  ||| S:10908 E:10922 ||| JJ
words ||| S:10922 E:10927 ||| NNS
,  ||| S:10927 E:10929 ||| ,
mRNAs  ||| S:10929 E:10935 ||| JJ
within  ||| S:10935 E:10942 ||| IN
each  ||| S:10942 E:10947 ||| DT
distinct  ||| S:10947 E:10956 ||| JJ
subcellular  ||| S:10956 E:10968 ||| NNS
compartment  ||| S:10968 E:10988 ||| VBP
clustered  ||| S:10988 E:10998 ||| VBN
more  ||| S:10998 E:11003 ||| RBR
closely  ||| S:11003 E:11011 ||| RB
together  ||| S:11011 E:11020 ||| RB
than  ||| S:11020 E:11025 ||| IN
those  ||| S:11025 E:11031 ||| DT
of  ||| S:11031 E:11034 ||| IN
the  ||| S:11034 E:11038 ||| DT
same  ||| S:11038 E:11043 ||| JJ
cell  ||| S:11043 E:11056 ||| NN
type ||| S:11056 E:11060 ||| NN
.  ||| S:11060 E:11062 ||| .
Thus ||| S:11062 E:11066 ||| RB
,  ||| S:11066 E:11068 ||| ,
the  ||| S:11068 E:11072 ||| DT
overall  ||| S:11072 E:11080 ||| JJ
subcellular  ||| S:11080 E:11092 ||| JJ
distribution  ||| S:11092 E:11105 ||| NN
of  ||| S:11105 E:11108 ||| IN
mRNAs  ||| S:11108 E:11122 ||| NNP
is  ||| S:11122 E:11125 ||| VBZ
largely  ||| S:11125 E:11133 ||| RB
conserved  ||| S:11133 E:11143 ||| VBN
across  ||| S:11143 E:11150 ||| IN
the  ||| S:11150 E:11154 ||| DT
two  ||| S:11154 E:11158 ||| CD
different  ||| S:11158 E:11168 ||| JJ
cell  ||| S:11168 E:11173 ||| NN
types  ||| S:11173 E:11187 ||| NNS
despite  ||| S:11187 E:11195 ||| IN
significant  ||| S:11195 E:11207 ||| JJ
changes  ||| S:11207 E:11215 ||| NNS
in  ||| S:11215 E:11218 ||| IN
cytoskeleton  ||| S:11218 E:11231 ||| JJ
architecture ||| S:11231 E:11243 ||| NN
,  ||| S:11243 E:11253 ||| ,
adhesive  ||| S:11253 E:11262 ||| JJ
state  ||| S:11262 E:11268 ||| NN
and  ||| S:11268 E:11272 ||| CC
cell  ||| S:11272 E:11277 ||| NN
morphology ||| S:11277 E:11287 ||| NN
.  ||| S:11287 E:11311 ||| .
Discussion  ||| S:11311 E:11330 ||| NNP
Interactions  ||| S:11330 E:11343 ||| NNP
between  ||| S:11343 E:11351 ||| IN
mRNA  ||| S:11351 E:11356 ||| JJ
and  ||| S:11356 E:11360 ||| CC
cytoskeleton  ||| S:11360 E:11373 ||| JJ
filaments  ||| S:11373 E:11383 ||| NNS
are  ||| S:11383 E:11395 ||| VBP
responsible  ||| S:11395 E:11407 ||| JJ
for  ||| S:11407 E:11411 ||| IN
the  ||| S:11411 E:11415 ||| DT
spatial  ||| S:11415 E:11423 ||| JJ
distribution  ||| S:11423 E:11436 ||| NN
and  ||| S:11436 E:11440 ||| CC
localized  ||| S:11440 E:11458 ||| JJ
function  ||| S:11458 E:11467 ||| NN
of  ||| S:11467 E:11470 ||| IN
several  ||| S:11470 E:11478 ||| JJ
transcripts  ||| S:11478 E:11490 ||| NNS
in  ||| S:11490 E:11493 ||| IN
somatic  ||| S:11493 E:11501 ||| JJ
cells  ||| S:11501 E:11507 ||| NNS
[  ||| S:11507 E:11509 ||| -LRB-
15  ||| S:11509 E:11512 ||| CD
16  ||| S:11512 E:11515 ||| CD
24  ||| S:11515 E:11526 ||| CD
]  ||| S:11526 E:11528 ||| -RRB-
.  ||| S:11528 E:11530 ||| .
However ||| S:11530 E:11537 ||| RB
,  ||| S:11537 E:11539 ||| ,
since  ||| S:11539 E:11545 ||| IN
only  ||| S:11545 E:11550 ||| RB
a  ||| S:11550 E:11552 ||| DT
small  ||| S:11552 E:11558 ||| JJ
number  ||| S:11558 E:11565 ||| NN
of  ||| S:11565 E:11568 ||| IN
localized  ||| S:11568 E:11578 ||| JJ
mRNAs  ||| S:11578 E:11592 ||| NNS
have  ||| S:11592 E:11597 ||| VBP
previously  ||| S:11597 E:11608 ||| RB
been  ||| S:11608 E:11613 ||| VBN
uncovered ||| S:11613 E:11622 ||| VBN
,  ||| S:11622 E:11624 ||| ,
it  ||| S:11624 E:11627 ||| PRP
is  ||| S:11627 E:11630 ||| VBZ
not  ||| S:11630 E:11634 ||| RB
known  ||| S:11634 E:11640 ||| VBN
to  ||| S:11640 E:11643 ||| TO
what  ||| S:11643 E:11656 ||| WP
extent  ||| S:11656 E:11663 ||| VBD
the  ||| S:11663 E:11667 ||| DT
association  ||| S:11667 E:11679 ||| NN
of  ||| S:11679 E:11682 ||| IN
RNAs  ||| S:11682 E:11687 ||| JJ
with  ||| S:11687 E:11692 ||| IN
the  ||| S:11692 E:11696 ||| DT
cytoskeleton  ||| S:11696 E:11709 ||| NN
might  ||| S:11709 E:11723 ||| MD
be  ||| S:11723 E:11726 ||| VB
a  ||| S:11726 E:11728 ||| DT
more  ||| S:11728 E:11733 ||| RBR
general  ||| S:11733 E:11741 ||| JJ
mechanism  ||| S:11741 E:11751 ||| NN
of  ||| S:11751 E:11754 ||| IN
gene  ||| S:11754 E:11759 ||| NN
regulation ||| S:11759 E:11769 ||| NN
.  ||| S:11769 E:11771 ||| .
Our  ||| S:11771 E:11775 ||| PRP$
data  ||| S:11775 E:11788 ||| NNS
suggest  ||| S:11788 E:11796 ||| VBP
that  ||| S:11796 E:11801 ||| IN
while  ||| S:11801 E:11807 ||| IN
many  ||| S:11807 E:11812 ||| JJ
mRNAs  ||| S:11812 E:11818 ||| NNS
distribute  ||| S:11818 E:11829 ||| VBP
equally  ||| S:11829 E:11837 ||| RB
between  ||| S:11837 E:11853 ||| IN
the  ||| S:11853 E:11857 ||| DT
cytosolic  ||| S:11857 E:11867 ||| NN
and  ||| S:11867 E:11871 ||| CC
cytoskeletal  ||| S:11871 E:11884 ||| JJ
fractions ||| S:11884 E:11893 ||| NNS
,  ||| S:11893 E:11895 ||| ,
a  ||| S:11895 E:11897 ||| DT
specific  ||| S:11897 E:11906 ||| JJ
set  ||| S:11906 E:11910 ||| NN
of  ||| S:11910 E:11921 ||| IN
transcripts  ||| S:11921 E:11933 ||| JJ
associates  ||| S:11933 E:11944 ||| NNS
preferentially  ||| S:11944 E:11959 ||| VBN
with  ||| S:11959 E:11964 ||| IN
actin  ||| S:11964 E:11978 ||| JJ
microfilaments ||| S:11978 E:11992 ||| NN
.  ||| S:11992 E:12002 ||| .
Furthermore ||| S:12002 E:12013 ||| RB
,  ||| S:12013 E:12015 ||| ,
this  ||| S:12015 E:12020 ||| DT
spatial  ||| S:12020 E:12028 ||| JJ
distribution  ||| S:12028 E:12041 ||| NN
pattern  ||| S:12041 E:12049 ||| NN
was  ||| S:12049 E:12061 ||| VBD
retained  ||| S:12061 E:12070 ||| VBN
even  ||| S:12070 E:12075 ||| RB
after  ||| S:12075 E:12081 ||| IN
the  ||| S:12081 E:12085 ||| DT
round  ||| S:12085 E:12091 ||| NN
HL-60  ||| S:12091 E:12097 ||| CD
cells  ||| S:12097 E:12103 ||| NNS
were  ||| S:12103 E:12108 ||| VBD
chemically  ||| S:12108 E:12127 ||| RB
induced  ||| S:12127 E:12135 ||| VBN
to  ||| S:12135 E:12138 ||| TO
differentiate  ||| S:12138 E:12152 ||| VB
into  ||| S:12152 E:12157 ||| IN
macrophages  ||| S:12157 E:12169 ||| NN
that  ||| S:12169 E:12174 ||| IN
adhere  ||| S:12174 E:12181 ||| NN
and  ||| S:12181 E:12193 ||| CC
spread  ||| S:12193 E:12200 ||| NN
on  ||| S:12200 E:12203 ||| IN
the  ||| S:12203 E:12207 ||| DT
culture  ||| S:12207 E:12215 ||| NN
substrate ||| S:12215 E:12224 ||| NN
,  ||| S:12224 E:12226 ||| ,
a  ||| S:12226 E:12228 ||| DT
process  ||| S:12228 E:12236 ||| NN
that  ||| S:12236 E:12241 ||| WDT
involves  ||| S:12241 E:12258 ||| VBZ
extensive  ||| S:12258 E:12268 ||| JJ
alterations  ||| S:12268 E:12280 ||| NN
in  ||| S:12280 E:12283 ||| IN
cytoskeletal  ||| S:12283 E:12296 ||| JJ
architecture  ||| S:12296 E:12309 ||| NN
and  ||| S:12309 E:12321 ||| CC
genome-wide  ||| S:12321 E:12333 ||| JJ
changes  ||| S:12333 E:12341 ||| NNS
in  ||| S:12341 E:12344 ||| IN
gene  ||| S:12344 E:12349 ||| NN
expression ||| S:12349 E:12359 ||| NN
.  ||| S:12359 E:12361 ||| .
Thus ||| S:12361 E:12365 ||| RB
,  ||| S:12365 E:12367 ||| ,
the  ||| S:12367 E:12379 ||| DT
cytoskeleton-associated  ||| S:12379 E:12403 ||| JJ
transcripts  ||| S:12403 E:12415 ||| NNS
may  ||| S:12415 E:12419 ||| MD
encode  ||| S:12419 E:12426 ||| VB
a  ||| S:12426 E:12428 ||| DT
core  ||| S:12428 E:12433 ||| NN
group  ||| S:12433 E:12447 ||| NN
of  ||| S:12447 E:12450 ||| IN
proteins  ||| S:12450 E:12459 ||| NNS
whose  ||| S:12459 E:12465 ||| WP$
expression  ||| S:12465 E:12476 ||| NN
may  ||| S:12476 E:12480 ||| MD
be  ||| S:12480 E:12483 ||| VB
regulated  ||| S:12483 E:12493 ||| VBN
at  ||| S:12493 E:12496 ||| IN
the  ||| S:12496 E:12508 ||| DT
post-transcriptional  ||| S:12508 E:12529 ||| JJ
level  ||| S:12529 E:12535 ||| NN
through  ||| S:12535 E:12543 ||| IN
their  ||| S:12543 E:12549 ||| PRP$
association  ||| S:12549 E:12561 ||| NN
with  ||| S:12561 E:12574 ||| IN
the  ||| S:12574 E:12578 ||| DT
components  ||| S:12578 E:12589 ||| NNS
of  ||| S:12589 E:12592 ||| IN
the  ||| S:12592 E:12596 ||| DT
actin  ||| S:12596 E:12602 ||| JJ
cytoskeleton  ||| S:12602 E:12615 ||| JJ
network ||| S:12615 E:12622 ||| NN
.  ||| S:12622 E:12632 ||| .
Consistent  ||| S:12632 E:12643 ||| JJ
with  ||| S:12643 E:12648 ||| IN
this  ||| S:12648 E:12653 ||| DT
hypothesis ||| S:12653 E:12663 ||| NN
,  ||| S:12663 E:12665 ||| ,
the  ||| S:12665 E:12669 ||| DT
majority  ||| S:12669 E:12678 ||| NN
of  ||| S:12678 E:12689 ||| IN
cytoskeleton-associated  ||| S:12689 E:12713 ||| JJ
transcripts  ||| S:12713 E:12725 ||| NNS
identified  ||| S:12725 E:12736 ||| VBN
in  ||| S:12736 E:12739 ||| IN
this  ||| S:12739 E:12752 ||| DT
study  ||| S:12752 E:12758 ||| NN
encoded  ||| S:12758 E:12766 ||| NN
proteins  ||| S:12766 E:12775 ||| NNS
that  ||| S:12775 E:12780 ||| WDT
modulate  ||| S:12780 E:12789 ||| VBP
cytoskeleton  ||| S:12789 E:12802 ||| JJ
structure  ||| S:12802 E:12820 ||| NN
or  ||| S:12820 E:12823 ||| CC
adhesion ||| S:12823 E:12831 ||| NN
.  ||| S:12831 E:12833 ||| .
Spectrin  ||| S:12833 E:12842 ||| NNP
and  ||| S:12842 E:12846 ||| CC
protein  ||| S:12846 E:12854 ||| NN
4.1  ||| S:12854 E:12858 ||| CD
form  ||| S:12858 E:12863 ||| NN
a  ||| S:12863 E:12865 ||| DT
complex  ||| S:12865 E:12873 ||| NN
with  ||| S:12873 E:12886 ||| IN
actin  ||| S:12886 E:12892 ||| JJ
filaments  ||| S:12892 E:12902 ||| NNS
[  ||| S:12902 E:12904 ||| -LRB-
17  ||| S:12904 E:12907 ||| CD
26  ||| S:12907 E:12910 ||| CD
]  ||| S:12910 E:12912 ||| -RRB-
that  ||| S:12912 E:12917 ||| WDT
may  ||| S:12917 E:12921 ||| MD
be  ||| S:12921 E:12924 ||| VB
important  ||| S:12924 E:12934 ||| JJ
in  ||| S:12934 E:12945 ||| IN
signaling  ||| S:12945 E:12955 ||| VBG
in  ||| S:12955 E:12958 ||| IN
additional  ||| S:12958 E:12969 ||| JJ
to  ||| S:12969 E:12972 ||| TO
forming  ||| S:12972 E:12980 ||| VB
a  ||| S:12980 E:12982 ||| DT
physical  ||| S:12982 E:12991 ||| JJ
link  ||| S:12991 E:12996 ||| NN
between  ||| S:12996 E:13012 ||| IN
the  ||| S:13012 E:13016 ||| DT
cytoskeletal  ||| S:13016 E:13029 ||| JJ
network  ||| S:13029 E:13037 ||| NN
and  ||| S:13037 E:13041 ||| CC
the  ||| S:13041 E:13045 ||| DT
cell  ||| S:13045 E:13050 ||| NN
membrane  ||| S:13050 E:13059 ||| NNS
[  ||| S:13059 E:13061 ||| -LRB-
27  ||| S:13061 E:13064 ||| CD
]  ||| S:13064 E:13066 ||| -RRB-
.  ||| S:13066 E:13076 ||| .
Furthermore ||| S:13076 E:13087 ||| RB
,  ||| S:13087 E:13089 ||| ,
PI4K  ||| S:13089 E:13094 ||| CD
activity  ||| S:13094 E:13103 ||| NN
has  ||| S:13103 E:13107 ||| VBZ
been  ||| S:13107 E:13112 ||| VBN
shown  ||| S:13112 E:13118 ||| VBN
to  ||| S:13118 E:13121 ||| TO
associate  ||| S:13121 E:13131 ||| NN
with  ||| S:13131 E:13144 ||| IN
the  ||| S:13144 E:13148 ||| DT
actin  ||| S:13148 E:13154 ||| JJ
cytoskeleton  ||| S:13154 E:13167 ||| NN
by  ||| S:13167 E:13170 ||| IN
biochemical  ||| S:13170 E:13182 ||| JJ
detergent  ||| S:13182 E:13192 ||| NN
extraction  ||| S:13192 E:13211 ||| NNS
[  ||| S:13211 E:13213 ||| -LRB-
28  ||| S:13213 E:13216 ||| CD
]  ||| S:13216 E:13218 ||| -RRB-
and  ||| S:13218 E:13222 ||| CC
is  ||| S:13222 E:13225 ||| VBZ
thought  ||| S:13225 E:13233 ||| VBN
to  ||| S:13233 E:13236 ||| TO
specifically  ||| S:13236 E:13249 ||| RB
localize  ||| S:13249 E:13258 ||| VBN
with  ||| S:13258 E:13263 ||| IN
α3β1  ||| S:13263 E:13276 ||| CD
integrin  ||| S:13276 E:13285 ||| NNS
[  ||| S:13285 E:13287 ||| -LRB-
29  ||| S:13287 E:13290 ||| CD
]  ||| S:13290 E:13292 ||| -RRB-
.  ||| S:13292 E:13294 ||| .
PI4K  ||| S:13294 E:13299 ||| NNP
catalyzes  ||| S:13299 E:13309 ||| VBD
the  ||| S:13309 E:13313 ||| DT
production  ||| S:13313 E:13324 ||| NN
of  ||| S:13324 E:13335 ||| IN
phosphatidylinositol-4-phosphate ||| S:13335 E:13367 ||| NNP
,  ||| S:13367 E:13369 ||| ,
an  ||| S:13369 E:13372 ||| DT
intermediate  ||| S:13372 E:13385 ||| JJ
in  ||| S:13385 E:13396 ||| IN
multiple  ||| S:13396 E:13405 ||| JJ
phosphatidylinositol  ||| S:13405 E:13426 ||| NNS
signaling  ||| S:13426 E:13436 ||| VBG
pathways  ||| S:13436 E:13445 ||| NNS
which  ||| S:13445 E:13459 ||| WDT
itself  ||| S:13459 E:13466 ||| PRP
can  ||| S:13466 E:13470 ||| MD
interact  ||| S:13470 E:13479 ||| VB
with  ||| S:13479 E:13484 ||| IN
actin  ||| S:13484 E:13490 ||| JJ
binding  ||| S:13490 E:13498 ||| JJ
proteins  ||| S:13498 E:13507 ||| NNS
to  ||| S:13507 E:13510 ||| TO
regulate  ||| S:13510 E:13527 ||| VB
microfilament  ||| S:13527 E:13541 ||| JJ
polymerization  ||| S:13541 E:13556 ||| NNS
[  ||| S:13556 E:13558 ||| -LRB-
30  ||| S:13558 E:13561 ||| CD
]  ||| S:13561 E:13563 ||| -RRB-
.  ||| S:13563 E:13565 ||| .
Our  ||| S:13565 E:13569 ||| PRP$
work  ||| S:13569 E:13574 ||| NN
now  ||| S:13574 E:13578 ||| RB
suggests  ||| S:13578 E:13595 ||| VBZ
that  ||| S:13595 E:13600 ||| IN
the  ||| S:13600 E:13604 ||| DT
mRNAs  ||| S:13604 E:13610 ||| JJ
of  ||| S:13610 E:13613 ||| IN
these  ||| S:13613 E:13619 ||| DT
proteins  ||| S:13619 E:13628 ||| NNS
are  ||| S:13628 E:13632 ||| VBP
all  ||| S:13632 E:13636 ||| RB
positioned  ||| S:13636 E:13647 ||| VBN
in  ||| S:13647 E:13658 ||| IN
close  ||| S:13658 E:13664 ||| JJ
association  ||| S:13664 E:13676 ||| NN
with  ||| S:13676 E:13681 ||| IN
the  ||| S:13681 E:13685 ||| DT
actin  ||| S:13685 E:13691 ||| JJ
cytoskeleton  ||| S:13691 E:13704 ||| NN
to  ||| S:13704 E:13707 ||| TO
permit  ||| S:13707 E:13722 ||| VB
efficient  ||| S:13722 E:13732 ||| JJ
localization  ||| S:13732 E:13745 ||| NN
of  ||| S:13745 E:13748 ||| IN
their  ||| S:13748 E:13754 ||| PRP$
protein  ||| S:13754 E:13762 ||| NN
products ||| S:13762 E:13770 ||| NNS
.  ||| S:13770 E:13780 ||| .
Given  ||| S:13780 E:13786 ||| VBN
the  ||| S:13786 E:13790 ||| DT
limited  ||| S:13790 E:13798 ||| JJ
sensitivity  ||| S:13798 E:13810 ||| NN
of  ||| S:13810 E:13813 ||| IN
DNA  ||| S:13813 E:13817 ||| NNP
arrays ||| S:13817 E:13823 ||| NN
,  ||| S:13823 E:13825 ||| ,
it  ||| S:13825 E:13828 ||| PRP
is  ||| S:13828 E:13839 ||| VBZ
possible  ||| S:13839 E:13848 ||| JJ
that  ||| S:13848 E:13853 ||| IN
the  ||| S:13853 E:13857 ||| DT
cytoskeleton  ||| S:13857 E:13870 ||| NN
may  ||| S:13870 E:13874 ||| MD
play  ||| S:13874 E:13879 ||| VB
a  ||| S:13879 E:13881 ||| DT
role  ||| S:13881 E:13886 ||| NN
in  ||| S:13886 E:13889 ||| IN
the  ||| S:13889 E:13901 ||| DT
localization  ||| S:13901 E:13914 ||| NN
and  ||| S:13914 E:13918 ||| CC
regulation  ||| S:13918 E:13929 ||| NN
of  ||| S:13929 E:13932 ||| IN
additional  ||| S:13932 E:13943 ||| JJ
cellular  ||| S:13943 E:13960 ||| JJ
transcripts  ||| S:13960 E:13972 ||| NNS
that  ||| S:13972 E:13977 ||| WDT
could  ||| S:13977 E:13983 ||| MD
not  ||| S:13983 E:13987 ||| RB
be  ||| S:13987 E:13990 ||| VB
detected  ||| S:13990 E:13999 ||| VBN
with  ||| S:13999 E:14004 ||| IN
the  ||| S:14004 E:14008 ||| DT
approach  ||| S:14008 E:14025 ||| NN
described  ||| S:14025 E:14035 ||| VBD
here ||| S:14035 E:14039 ||| RB
.  ||| S:14039 E:14041 ||| .
Abundant  ||| S:14041 E:14050 ||| JJ
mRNA  ||| S:14050 E:14055 ||| JJ
species  ||| S:14055 E:14063 ||| NNS
may  ||| S:14063 E:14067 ||| MD
target  ||| S:14067 E:14074 ||| VB
only  ||| S:14074 E:14079 ||| RB
a  ||| S:14079 E:14089 ||| DT
miniscule  ||| S:14089 E:14099 ||| JJ
fraction  ||| S:14099 E:14108 ||| NN
of  ||| S:14108 E:14111 ||| IN
mRNA  ||| S:14111 E:14116 ||| JJ
molecules  ||| S:14116 E:14126 ||| NNS
to  ||| S:14126 E:14129 ||| TO
the  ||| S:14129 E:14133 ||| DT
cytoskeleton ||| S:14133 E:14145 ||| NN
;  ||| S:14145 E:14155 ||| :
this  ||| S:14155 E:14160 ||| DT
may  ||| S:14160 E:14164 ||| MD
be  ||| S:14164 E:14167 ||| VB
the  ||| S:14167 E:14171 ||| DT
functionally  ||| S:14171 E:14184 ||| JJ
important  ||| S:14184 E:14194 ||| JJ
fraction  ||| S:14194 E:14203 ||| NN
but  ||| S:14203 E:14207 ||| CC
its  ||| S:14207 E:14219 ||| PRP$
relevance  ||| S:14219 E:14229 ||| NN
would  ||| S:14229 E:14235 ||| MD
not  ||| S:14235 E:14239 ||| RB
be  ||| S:14239 E:14242 ||| VB
revealed  ||| S:14242 E:14251 ||| VBN
using  ||| S:14251 E:14257 ||| VBG
this  ||| S:14257 E:14262 ||| DT
method ||| S:14262 E:14268 ||| NN
.  ||| S:14268 E:14270 ||| .
On  ||| S:14270 E:14273 ||| IN
the  ||| S:14273 E:14285 ||| DT
other  ||| S:14285 E:14291 ||| JJ
hand ||| S:14291 E:14295 ||| NN
,  ||| S:14295 E:14297 ||| ,
mRNAs  ||| S:14297 E:14303 ||| JJ
of  ||| S:14303 E:14306 ||| IN
lowly  ||| S:14306 E:14312 ||| NN
expressed  ||| S:14312 E:14322 ||| VBD
genes  ||| S:14322 E:14328 ||| NNS
may  ||| S:14328 E:14332 ||| MD
be  ||| S:14332 E:14335 ||| VB
entirely  ||| S:14335 E:14352 ||| RB
associated  ||| S:14352 E:14363 ||| VBN
with  ||| S:14363 E:14368 ||| IN
the  ||| S:14368 E:14372 ||| DT
cytoskeleton  ||| S:14372 E:14385 ||| NN
but  ||| S:14385 E:14389 ||| CC
may  ||| S:14389 E:14393 ||| MD
fall  ||| S:14393 E:14398 ||| VB
below  ||| S:14398 E:14404 ||| IN
the  ||| S:14404 E:14416 ||| DT
limits  ||| S:14416 E:14423 ||| NNS
of  ||| S:14423 E:14426 ||| IN
microarray  ||| S:14426 E:14437 ||| JJ
detection ||| S:14437 E:14446 ||| NN
.  ||| S:14446 E:14448 ||| .
For  ||| S:14448 E:14452 ||| IN
the  ||| S:14452 E:14456 ||| DT
majority  ||| S:14456 E:14465 ||| NN
of  ||| S:14465 E:14468 ||| IN
gene  ||| S:14468 E:14481 ||| NN
transcripts ||| S:14481 E:14492 ||| NNS
,  ||| S:14492 E:14494 ||| ,
the  ||| S:14494 E:14498 ||| DT
relationship  ||| S:14498 E:14511 ||| NN
between  ||| S:14511 E:14519 ||| IN
mRNA  ||| S:14519 E:14524 ||| JJ
localization  ||| S:14524 E:14537 ||| NN
and  ||| S:14537 E:14549 ||| CC
translational  ||| S:14549 E:14563 ||| JJ
activation  ||| S:14563 E:14574 ||| NN
remains  ||| S:14574 E:14582 ||| VBZ
unclear ||| S:14582 E:14589 ||| JJ
.  ||| S:14589 E:14591 ||| .
It  ||| S:14591 E:14594 ||| PRP
is  ||| S:14594 E:14597 ||| VBZ
therefore  ||| S:14597 E:14615 ||| RB
possible  ||| S:14615 E:14624 ||| JJ
that  ||| S:14624 E:14629 ||| IN
although  ||| S:14629 E:14638 ||| IN
only  ||| S:14638 E:14643 ||| RB
a  ||| S:14643 E:14645 ||| DT
small  ||| S:14645 E:14651 ||| JJ
fraction  ||| S:14651 E:14660 ||| NN
of  ||| S:14660 E:14663 ||| IN
a  ||| S:14663 E:14673 ||| DT
particular  ||| S:14673 E:14684 ||| JJ
transcript  ||| S:14684 E:14695 ||| NN
associates  ||| S:14695 E:14706 ||| NNS
with  ||| S:14706 E:14711 ||| IN
the  ||| S:14711 E:14715 ||| DT
cytoskeleton ||| S:14715 E:14727 ||| NN
,  ||| S:14727 E:14737 ||| ,
these  ||| S:14737 E:14743 ||| DT
localized  ||| S:14743 E:14753 ||| JJ
molecules  ||| S:14753 E:14763 ||| NNS
might  ||| S:14763 E:14769 ||| MD
actually  ||| S:14769 E:14778 ||| RB
represent  ||| S:14778 E:14788 ||| VB
the  ||| S:14788 E:14800 ||| DT
actively  ||| S:14800 E:14809 ||| RB
translated  ||| S:14809 E:14820 ||| VBN
subpopulation ||| S:14820 E:14833 ||| NN
.  ||| S:14833 E:14843 ||| .
This  ||| S:14843 E:14848 ||| DT
naturally  ||| S:14848 E:14858 ||| RB
raises  ||| S:14858 E:14865 ||| VBZ
the  ||| S:14865 E:14869 ||| DT
question  ||| S:14869 E:14878 ||| NN
of  ||| S:14878 E:14881 ||| IN
whether  ||| S:14881 E:14889 ||| IN
the  ||| S:14889 E:14901 ||| DT
cytoskeleton-associated  ||| S:14901 E:14925 ||| JJ
transcripts  ||| S:14925 E:14937 ||| NNS
are  ||| S:14937 E:14941 ||| VBP
differentially  ||| S:14941 E:14964 ||| VBN
expressed  ||| S:14964 E:14974 ||| VBN
in  ||| S:14974 E:14977 ||| IN
promyelocyte  ||| S:14977 E:14990 ||| NN
and  ||| S:14990 E:14994 ||| CC
macrophage  ||| S:14994 E:15005 ||| JJ
cells ||| S:15005 E:15010 ||| NNS
.  ||| S:15010 E:15012 ||| .
Tamayo  ||| S:15012 E:15028 ||| FW
et  ||| S:15028 E:15031 ||| FW
al.  ||| S:15031 E:15035 ||| FW
have  ||| S:15035 E:15040 ||| VBP
previously  ||| S:15040 E:15051 ||| RB
monitored  ||| S:15051 E:15061 ||| VBN
gene  ||| S:15061 E:15074 ||| NN
expression  ||| S:15074 E:15085 ||| NN
at  ||| S:15085 E:15088 ||| IN
various  ||| S:15088 E:15096 ||| JJ
time  ||| S:15096 E:15101 ||| NN
points  ||| S:15101 E:15108 ||| NNS
following  ||| S:15108 E:15118 ||| VBG
phorbol  ||| S:15118 E:15134 ||| JJ
ester-induced  ||| S:15134 E:15148 ||| JJ
differentiation  ||| S:15148 E:15164 ||| NN
in  ||| S:15164 E:15167 ||| IN
the  ||| S:15167 E:15171 ||| DT
same  ||| S:15171 E:15176 ||| JJ
HL-60  ||| S:15176 E:15182 ||| CD
cell  ||| S:15182 E:15187 ||| NN
system  ||| S:15187 E:15202 ||| NN
[  ||| S:15202 E:15204 ||| -LRB-
22  ||| S:15204 E:15207 ||| CD
]  ||| S:15207 E:15209 ||| -RRB-
.  ||| S:15209 E:15211 ||| .
Thirteen  ||| S:15211 E:15220 ||| NNP
of  ||| S:15220 E:15223 ||| IN
the  ||| S:15223 E:15227 ||| DT
22  ||| S:15227 E:15230 ||| CD
transcripts  ||| S:15230 E:15242 ||| NNS
we  ||| S:15242 E:15245 ||| PRP
identified  ||| S:15245 E:15256 ||| VBD
as  ||| S:15256 E:15267 ||| IN
cytoskeleton-associated  ||| S:15267 E:15291 ||| NNP
were  ||| S:15291 E:15296 ||| VBD
also  ||| S:15296 E:15301 ||| RB
assayed  ||| S:15301 E:15309 ||| VBN
in  ||| S:15309 E:15312 ||| IN
that  ||| S:15312 E:15317 ||| DT
study  ||| S:15317 E:15323 ||| NN
by  ||| S:15323 E:15334 ||| IN
Tamayo ||| S:15334 E:15340 ||| NNP
,  ||| S:15340 E:15351 ||| ,
et  ||| S:15351 E:15354 ||| FW
al  ||| S:15354 E:15357 ||| FW
[  ||| S:15357 E:15359 ||| -LRB-
22  ||| S:15359 E:15362 ||| CD
]  ||| S:15362 E:15364 ||| -RRB-
.  ||| S:15364 E:15366 ||| .
Only  ||| S:15366 E:15371 ||| RB
two  ||| S:15371 E:15375 ||| CD
of  ||| S:15375 E:15378 ||| IN
these  ||| S:15378 E:15392 ||| DT
transcripts-alpha  ||| S:15392 E:15410 ||| JJ
spectrin  ||| S:15410 E:15419 ||| NN
and  ||| S:15419 E:15423 ||| CC
pim-1  ||| S:15423 E:15429 ||| NNP
were  ||| S:15429 E:15434 ||| VBD
found  ||| S:15434 E:15440 ||| VBN
to  ||| S:15440 E:15443 ||| TO
vary  ||| S:15443 E:15456 ||| VB
significantly ||| S:15456 E:15469 ||| RB
,  ||| S:15469 E:15471 ||| ,
in  ||| S:15471 E:15474 ||| IN
that  ||| S:15474 E:15479 ||| IN
the  ||| S:15479 E:15483 ||| DT
expression  ||| S:15483 E:15494 ||| NN
of  ||| S:15494 E:15497 ||| IN
both  ||| S:15497 E:15502 ||| DT
genes  ||| S:15502 E:15508 ||| NNS
was  ||| S:15508 E:15520 ||| VBD
undetectable  ||| S:15520 E:15533 ||| VBN
in  ||| S:15533 E:15536 ||| IN
the  ||| S:15536 E:15540 ||| DT
promyelocytic  ||| S:15540 E:15554 ||| JJ
cell  ||| S:15554 E:15559 ||| NN
type  ||| S:15559 E:15564 ||| NN
and  ||| S:15564 E:15568 ||| CC
increased  ||| S:15568 E:15586 ||| VBD
dramatically  ||| S:15586 E:15599 ||| RB
upon  ||| S:15599 E:15604 ||| IN
differentiation  ||| S:15604 E:15620 ||| VBG
to  ||| S:15620 E:15623 ||| TO
the  ||| S:15623 E:15627 ||| DT
macrophage  ||| S:15627 E:15638 ||| JJ
cell  ||| S:15638 E:15651 ||| NN
type ||| S:15651 E:15655 ||| NN
.  ||| S:15655 E:15657 ||| .
Future  ||| S:15657 E:15664 ||| JJ
work  ||| S:15664 E:15669 ||| NN
in  ||| S:15669 E:15672 ||| IN
this  ||| S:15672 E:15677 ||| DT
area  ||| S:15677 E:15682 ||| NN
might  ||| S:15682 E:15688 ||| MD
address  ||| S:15688 E:15696 ||| VB
the  ||| S:15696 E:15700 ||| DT
potential  ||| S:15700 E:15718 ||| JJ
relationship  ||| S:15718 E:15731 ||| NN
between  ||| S:15731 E:15739 ||| IN
cytoskeleton-localization  ||| S:15739 E:15765 ||| JJ
and  ||| S:15765 E:15777 ||| CC
expression  ||| S:15777 E:15788 ||| NN
of  ||| S:15788 E:15791 ||| IN
these  ||| S:15791 E:15797 ||| DT
transcripts ||| S:15797 E:15808 ||| NNS
.  ||| S:15808 E:15818 ||| .
As  ||| S:15818 E:15821 ||| IN
a  ||| S:15821 E:15823 ||| DT
mechanosensitive  ||| S:15823 E:15840 ||| JJ
scaffold  ||| S:15840 E:15849 ||| NN
that  ||| S:15849 E:15854 ||| WDT
controls  ||| S:15854 E:15863 ||| VBZ
a  ||| S:15863 E:15865 ||| DT
large  ||| S:15865 E:15871 ||| JJ
set  ||| S:15871 E:15883 ||| NN
of  ||| S:15883 E:15886 ||| IN
regulatory  ||| S:15886 E:15897 ||| JJ
proteins ||| S:15897 E:15905 ||| NNS
,  ||| S:15905 E:15907 ||| ,
the  ||| S:15907 E:15911 ||| DT
actin  ||| S:15911 E:15917 ||| JJ
cytoskeleton  ||| S:15917 E:15930 ||| NN
is  ||| S:15930 E:15941 ||| VBZ
critically  ||| S:15941 E:15952 ||| RB
poised  ||| S:15952 E:15959 ||| VBN
to  ||| S:15959 E:15962 ||| TO
modulate  ||| S:15962 E:15971 ||| VB
a  ||| S:15971 E:15973 ||| DT
variety  ||| S:15973 E:15981 ||| NN
of  ||| S:15981 E:15984 ||| IN
cellular  ||| S:15984 E:16001 ||| JJ
processes ||| S:16001 E:16010 ||| NNS
,  ||| S:16010 E:16012 ||| ,
including  ||| S:16012 E:16022 ||| VBG
protein  ||| S:16022 E:16030 ||| NN
synthesis ||| S:16030 E:16039 ||| NN
,  ||| S:16039 E:16041 ||| ,
cell  ||| S:16041 E:16046 ||| NN
survival ||| S:16046 E:16054 ||| NN
,  ||| S:16054 E:16064 ||| ,
migration  ||| S:16064 E:16074 ||| NN
and  ||| S:16074 E:16078 ||| CC
proliferation  ||| S:16078 E:16092 ||| NN
[  ||| S:16092 E:16094 ||| -LRB-
14  ||| S:16094 E:16097 ||| CD
31  ||| S:16097 E:16100 ||| CD
32  ||| S:16100 E:16103 ||| CD
]  ||| S:16103 E:16105 ||| -RRB-
.  ||| S:16105 E:16107 ||| .
One  ||| S:16107 E:16111 ||| CD
function  ||| S:16111 E:16120 ||| NN
of  ||| S:16120 E:16131 ||| IN
the  ||| S:16131 E:16135 ||| DT
cytoskeleton  ||| S:16135 E:16148 ||| NN
in  ||| S:16148 E:16151 ||| IN
gene  ||| S:16151 E:16156 ||| NN
regulation  ||| S:16156 E:16167 ||| NN
appears  ||| S:16167 E:16175 ||| VBZ
to  ||| S:16175 E:16178 ||| TO
be  ||| S:16178 E:16181 ||| VB
the  ||| S:16181 E:16193 ||| DT
spatial  ||| S:16193 E:16201 ||| JJ
organization  ||| S:16201 E:16214 ||| NN
of  ||| S:16214 E:16217 ||| IN
transcripts  ||| S:16217 E:16229 ||| NNS
and  ||| S:16229 E:16233 ||| CC
possibly  ||| S:16233 E:16242 ||| RB
their  ||| S:16242 E:16256 ||| PRP$
translation  ||| S:16256 E:16268 ||| NN
within  ||| S:16268 E:16275 ||| IN
the  ||| S:16275 E:16279 ||| DT
intracellular  ||| S:16279 E:16293 ||| JJ
environment ||| S:16293 E:16304 ||| NN
.  ||| S:16304 E:16306 ||| .
Our  ||| S:16306 E:16310 ||| PRP$
work  ||| S:16310 E:16323 ||| NN
demonstrates  ||| S:16323 E:16336 ||| VBZ
that  ||| S:16336 E:16341 ||| IN
a  ||| S:16341 E:16343 ||| DT
subset  ||| S:16343 E:16350 ||| NN
of  ||| S:16350 E:16353 ||| IN
gene  ||| S:16353 E:16358 ||| NN
transcripts  ||| S:16358 E:16370 ||| NNS
interacts  ||| S:16370 E:16388 ||| VBN
with  ||| S:16388 E:16393 ||| IN
the  ||| S:16393 E:16397 ||| DT
actin  ||| S:16397 E:16403 ||| JJ
cytoskeleton  ||| S:16403 E:16416 ||| NN
and  ||| S:16416 E:16420 ||| CC
that  ||| S:16420 E:16425 ||| IN
this  ||| S:16425 E:16430 ||| DT
subpopulation  ||| S:16430 E:16452 ||| NN
includes  ||| S:16452 E:16461 ||| VBZ
a  ||| S:16461 E:16463 ||| DT
number  ||| S:16463 E:16470 ||| NN
of  ||| S:16470 E:16473 ||| IN
structural  ||| S:16473 E:16484 ||| JJ
and  ||| S:16484 E:16488 ||| CC
cytoskeleton-modulating  ||| S:16488 E:16520 ||| JJ
proteins  ||| S:16520 E:16529 ||| NNS
as  ||| S:16529 E:16532 ||| IN
well  ||| S:16532 E:16537 ||| RB
as  ||| S:16537 E:16540 ||| IN
molecules  ||| S:16540 E:16550 ||| NNS
involved  ||| S:16550 E:16559 ||| VBN
in  ||| S:16559 E:16562 ||| IN
protein  ||| S:16562 E:16578 ||| NN
translation ||| S:16578 E:16589 ||| NN
.  ||| S:16589 E:16591 ||| .
This  ||| S:16591 E:16596 ||| DT
finding  ||| S:16596 E:16604 ||| NN
is  ||| S:16604 E:16607 ||| VBZ
consistent  ||| S:16607 E:16618 ||| JJ
with  ||| S:16618 E:16623 ||| IN
the  ||| S:16623 E:16627 ||| DT
hypothesis  ||| S:16627 E:16646 ||| NN
that  ||| S:16646 E:16651 ||| IN
cellular  ||| S:16651 E:16660 ||| JJ
evolution  ||| S:16660 E:16670 ||| NN
resulted  ||| S:16670 E:16679 ||| VBD
from  ||| S:16679 E:16684 ||| IN
self-assembly  ||| S:16684 E:16698 ||| JJ
of  ||| S:16698 E:16709 ||| IN
molecular  ||| S:16709 E:16719 ||| JJ
scaffolds ||| S:16719 E:16728 ||| NN
,  ||| S:16728 E:16730 ||| ,
like  ||| S:16730 E:16735 ||| IN
the  ||| S:16735 E:16739 ||| DT
actin  ||| S:16739 E:16745 ||| JJ
cytoskeleton ||| S:16745 E:16757 ||| NN
,  ||| S:16757 E:16759 ||| ,
that  ||| S:16759 E:16772 ||| WDT
provide  ||| S:16772 E:16780 ||| VBP
simultaneous  ||| S:16780 E:16793 ||| JJ
structural  ||| S:16793 E:16804 ||| JJ
and  ||| S:16804 E:16808 ||| CC
biochemical  ||| S:16808 E:16820 ||| JJ
functions ||| S:16820 E:16829 ||| NNS
,  ||| S:16829 E:16839 ||| ,
including  ||| S:16839 E:16849 ||| VBG
orienting  ||| S:16849 E:16859 ||| JJ
mRNA  ||| S:16859 E:16864 ||| JJ
transcripts  ||| S:16864 E:16876 ||| NNS
and  ||| S:16876 E:16880 ||| CC
facilitating  ||| S:16880 E:16893 ||| VBG
their  ||| S:16893 E:16907 ||| PRP$
translation  ||| S:16907 E:16919 ||| NN
into  ||| S:16919 E:16924 ||| IN
proteins  ||| S:16924 E:16933 ||| NNS
that  ||| S:16933 E:16938 ||| IN
self-assemble  ||| S:16938 E:16952 ||| JJ
into  ||| S:16952 E:16957 ||| IN
the  ||| S:16957 E:16961 ||| DT
very  ||| S:16961 E:16974 ||| RB
scaffolds  ||| S:16974 E:16984 ||| VBN
to  ||| S:16984 E:16987 ||| TO
which  ||| S:16987 E:16993 ||| WDT
they  ||| S:16993 E:16998 ||| PRP
associate  ||| S:16998 E:17008 ||| VBP
[  ||| S:17008 E:17010 ||| -LRB-
33  ||| S:17010 E:17013 ||| CD
]  ||| S:17013 E:17015 ||| -RRB-
.  ||| S:17015 E:17025 ||| .
In  ||| S:17025 E:17028 ||| IN
summary ||| S:17028 E:17035 ||| NN
,  ||| S:17035 E:17037 ||| ,
this  ||| S:17037 E:17042 ||| DT
work  ||| S:17042 E:17047 ||| NN
extends  ||| S:17047 E:17055 ||| VBZ
our  ||| S:17055 E:17059 ||| PRP$
view  ||| S:17059 E:17064 ||| NN
of  ||| S:17064 E:17075 ||| IN
post-transcriptional  ||| S:17075 E:17096 ||| JJ
control  ||| S:17096 E:17104 ||| NN
of  ||| S:17104 E:17107 ||| IN
gene  ||| S:17107 E:17112 ||| NN
expression  ||| S:17112 E:17123 ||| NN
by  ||| S:17123 E:17134 ||| IN
revealing  ||| S:17134 E:17144 ||| VBG
that  ||| S:17144 E:17149 ||| IN
multiple  ||| S:17149 E:17158 ||| JJ
transcripts  ||| S:17158 E:17170 ||| NNS
involved  ||| S:17170 E:17179 ||| VBN
in  ||| S:17179 E:17182 ||| IN
cellular  ||| S:17182 E:17199 ||| JJ
regulation  ||| S:17199 E:17210 ||| NN
associate  ||| S:17210 E:17220 ||| NN
with  ||| S:17220 E:17225 ||| IN
the  ||| S:17225 E:17229 ||| DT
actin  ||| S:17229 E:17235 ||| JJ
cytoskeleton ||| S:17235 E:17247 ||| NN
.  ||| S:17247 E:17249 ||| .
The  ||| S:17249 E:17261 ||| DT
subcellular  ||| S:17261 E:17273 ||| JJ
localization  ||| S:17273 E:17286 ||| NN
of  ||| S:17286 E:17289 ||| IN
the  ||| S:17289 E:17293 ||| DT
majority  ||| S:17293 E:17302 ||| NN
of  ||| S:17302 E:17305 ||| IN
these  ||| S:17305 E:17319 ||| DT
transcripts  ||| S:17319 E:17331 ||| NNS
had  ||| S:17331 E:17335 ||| VBD
not  ||| S:17335 E:17339 ||| RB
been  ||| S:17339 E:17344 ||| VBN
previously  ||| S:17344 E:17355 ||| RB
investigated ||| S:17355 E:17367 ||| VBN
.  ||| S:17367 E:17369 ||| .
It  ||| S:17369 E:17380 ||| PRP
appears  ||| S:17380 E:17388 ||| VBZ
that  ||| S:17388 E:17393 ||| DT
information  ||| S:17393 E:17405 ||| NN
about  ||| S:17405 E:17411 ||| IN
the  ||| S:17411 E:17415 ||| DT
spatial  ||| S:17415 E:17423 ||| JJ
context  ||| S:17423 E:17431 ||| NN
of  ||| S:17431 E:17434 ||| IN
an  ||| S:17434 E:17445 ||| DT
mRNA  ||| S:17445 E:17450 ||| JJ
species ||| S:17450 E:17457 ||| NNS
,  ||| S:17457 E:17459 ||| ,
in  ||| S:17459 E:17462 ||| IN
addition  ||| S:17462 E:17471 ||| NN
to  ||| S:17471 E:17474 ||| TO
knowledge  ||| S:17474 E:17484 ||| NN
of  ||| S:17484 E:17487 ||| IN
its  ||| S:17487 E:17491 ||| PRP$
temporal  ||| S:17491 E:17508 ||| JJ
expression  ||| S:17508 E:17519 ||| NN
pattern ||| S:17519 E:17526 ||| NN
,  ||| S:17526 E:17528 ||| ,
may  ||| S:17528 E:17532 ||| MD
be  ||| S:17532 E:17535 ||| VB
necessary  ||| S:17535 E:17545 ||| JJ
for  ||| S:17545 E:17549 ||| IN
a  ||| S:17549 E:17551 ||| DT
more  ||| S:17551 E:17556 ||| RBR
complete  ||| S:17556 E:17573 ||| JJ
view  ||| S:17573 E:17578 ||| NN
of  ||| S:17578 E:17581 ||| IN
gene  ||| S:17581 E:17586 ||| NN
regulation ||| S:17586 E:17596 ||| NN
.  ||| S:17596 E:17598 ||| .
Thus ||| S:17598 E:17602 ||| RB
,  ||| S:17602 E:17604 ||| ,
a  ||| S:17604 E:17606 ||| DT
combination  ||| S:17606 E:17618 ||| NN
of  ||| S:17618 E:17621 ||| IN
other  ||| S:17621 E:17635 ||| JJ
biochemical  ||| S:17635 E:17647 ||| JJ
fractionation  ||| S:17647 E:17661 ||| JJ
techniques  ||| S:17661 E:17672 ||| NNS
( ||| S:17672 E:17673 ||| -LRB-
e.g. ||| S:17673 E:17677 ||| NNP
,  ||| S:17677 E:17679 ||| ,
isolation  ||| S:17679 E:17689 ||| NN
of  ||| S:17689 E:17700 ||| IN
microtubule  ||| S:17700 E:17712 ||| NN
or  ||| S:17712 E:17715 ||| CC
intermediate  ||| S:17715 E:17728 ||| JJ
filament  ||| S:17728 E:17737 ||| JJ
cytoskeleton  ||| S:17737 E:17758 ||| JJ
compartments ||| S:17758 E:17770 ||| NN
,  ||| S:17770 E:17772 ||| ,
nuclear  ||| S:17772 E:17780 ||| JJ
matrix ||| S:17780 E:17786 ||| NN
,  ||| S:17786 E:17788 ||| ,
etc. ||| S:17788 E:17792 ||| FW
)  ||| S:17792 E:17794 ||| -RRB-
with  ||| S:17794 E:17799 ||| IN
massively  ||| S:17799 E:17809 ||| JJ
parallel  ||| S:17809 E:17826 ||| JJ
gene  ||| S:17826 E:17831 ||| NN
profiling  ||| S:17831 E:17841 ||| NN
technology  ||| S:17841 E:17852 ||| NN
may  ||| S:17852 E:17856 ||| MD
provide  ||| S:17856 E:17864 ||| VB
additional  ||| S:17864 E:17875 ||| JJ
insights  ||| S:17875 E:17892 ||| NNS
into  ||| S:17892 E:17897 ||| IN
cellular  ||| S:17897 E:17906 ||| JJ
regulation ||| S:17906 E:17916 ||| NN
.  ||| S:17916 E:17940 ||| .
Conclusions  ||| S:17940 E:17960 ||| NNS
In  ||| S:17960 E:17963 ||| IN
this  ||| S:17963 E:17968 ||| DT
work ||| S:17968 E:17972 ||| NN
,  ||| S:17972 E:17974 ||| ,
we  ||| S:17974 E:17977 ||| PRP
set  ||| S:17977 E:17981 ||| VBD
out  ||| S:17981 E:17985 ||| RP
to  ||| S:17985 E:17988 ||| TO
explore  ||| S:17988 E:17996 ||| VB
the  ||| S:17996 E:18000 ||| DT
extent  ||| S:18000 E:18007 ||| NN
to  ||| S:18007 E:18010 ||| TO
which  ||| S:18010 E:18024 ||| WDT
somatic  ||| S:18024 E:18032 ||| JJ
cell  ||| S:18032 E:18037 ||| NN
transcripts  ||| S:18037 E:18049 ||| NNS
associate  ||| S:18049 E:18059 ||| VBP
with  ||| S:18059 E:18064 ||| IN
the  ||| S:18064 E:18068 ||| DT
cytoskeleton  ||| S:18068 E:18089 ||| NN
and  ||| S:18089 E:18093 ||| CC
to  ||| S:18093 E:18096 ||| TO
identify  ||| S:18096 E:18105 ||| VB
the  ||| S:18105 E:18109 ||| DT
specific  ||| S:18109 E:18118 ||| JJ
transcripts  ||| S:18118 E:18130 ||| NNS
that  ||| S:18130 E:18135 ||| WDT
might  ||| S:18135 E:18141 ||| MD
be  ||| S:18141 E:18152 ||| VB
regulated  ||| S:18152 E:18162 ||| VBN
through  ||| S:18162 E:18170 ||| IN
cytoskeleton  ||| S:18170 E:18183 ||| JJ
localization ||| S:18183 E:18195 ||| NN
.  ||| S:18195 E:18197 ||| .
A  ||| S:18197 E:18199 ||| DT
set  ||| S:18199 E:18203 ||| NN
of  ||| S:18203 E:18206 ||| IN
22  ||| S:18206 E:18217 ||| CD
transcripts ||| S:18217 E:18228 ||| NNS
,  ||| S:18228 E:18230 ||| ,
encoding  ||| S:18230 E:18239 ||| JJ
structural  ||| S:18239 E:18250 ||| JJ
proteins ||| S:18250 E:18258 ||| NNS
,  ||| S:18258 E:18260 ||| ,
cytoskeletal  ||| S:18260 E:18281 ||| JJ
proteins  ||| S:18281 E:18290 ||| NNS
and  ||| S:18290 E:18294 ||| CC
components  ||| S:18294 E:18305 ||| NNS
of  ||| S:18305 E:18308 ||| IN
the  ||| S:18308 E:18312 ||| DT
translation  ||| S:18312 E:18324 ||| NN
machinery ||| S:18324 E:18333 ||| NN
,  ||| S:18333 E:18335 ||| ,
was  ||| S:18335 E:18347 ||| VBD
shown  ||| S:18347 E:18353 ||| VBN
to  ||| S:18353 E:18356 ||| TO
be  ||| S:18356 E:18359 ||| VB
highly  ||| S:18359 E:18366 ||| RB
enriched  ||| S:18366 E:18375 ||| VBN
in  ||| S:18375 E:18378 ||| IN
the  ||| S:18378 E:18382 ||| DT
cytoskeleton-associated  ||| S:18382 E:18414 ||| JJ
population  ||| S:18414 E:18425 ||| NN
of  ||| S:18425 E:18428 ||| IN
HL-60  ||| S:18428 E:18434 ||| CD
cells ||| S:18434 E:18439 ||| NNS
.  ||| S:18439 E:18441 ||| .
Intact  ||| S:18441 E:18448 ||| JJ
actin  ||| S:18448 E:18454 ||| JJ
microfilaments  ||| S:18454 E:18469 ||| NN
were  ||| S:18469 E:18482 ||| VBD
required  ||| S:18482 E:18491 ||| VBN
for  ||| S:18491 E:18495 ||| IN
the  ||| S:18495 E:18499 ||| DT
localization  ||| S:18499 E:18512 ||| NN
and ||| S:18512 E:18515 ||| CC
/ ||| S:18515 E:18516 ||| NNP
or  ||| S:18516 E:18519 ||| CC
anchoring  ||| S:18519 E:18529 ||| NN
of  ||| S:18529 E:18532 ||| IN
these  ||| S:18532 E:18546 ||| DT
transcripts ||| S:18546 E:18557 ||| NNS
.  ||| S:18557 E:18559 ||| .
In  ||| S:18559 E:18562 ||| IN
addition ||| S:18562 E:18570 ||| NN
,  ||| S:18570 E:18572 ||| ,
this  ||| S:18572 E:18577 ||| DT
study  ||| S:18577 E:18583 ||| NN
emphasizes  ||| S:18583 E:18594 ||| VBZ
the  ||| S:18594 E:18598 ||| DT
value  ||| S:18598 E:18612 ||| NN
of  ||| S:18612 E:18615 ||| IN
using  ||| S:18615 E:18621 ||| VBG
subcellular  ||| S:18621 E:18633 ||| JJ
fractionation  ||| S:18633 E:18647 ||| NN
to  ||| S:18647 E:18650 ||| TO
expand  ||| S:18650 E:18657 ||| VB
the  ||| S:18657 E:18661 ||| DT
range  ||| S:18661 E:18667 ||| NN
of  ||| S:18667 E:18678 ||| IN
genome-wide  ||| S:18678 E:18690 ||| JJ
technologies  ||| S:18690 E:18703 ||| NNS
by  ||| S:18703 E:18706 ||| IN
providing  ||| S:18706 E:18716 ||| VBG
information  ||| S:18716 E:18728 ||| NN
about  ||| S:18728 E:18734 ||| IN
the  ||| S:18734 E:18746 ||| DT
spatial  ||| S:18746 E:18754 ||| JJ
distribution  ||| S:18754 E:18767 ||| NN
of  ||| S:18767 E:18770 ||| IN
a  ||| S:18770 E:18772 ||| DT
transcript ||| S:18772 E:18782 ||| NN
,  ||| S:18782 E:18784 ||| ,
in  ||| S:18784 E:18787 ||| IN
addition  ||| S:18787 E:18796 ||| NN
to  ||| S:18796 E:18799 ||| TO
its  ||| S:18799 E:18811 ||| PRP$
expression  ||| S:18811 E:18822 ||| NN
level ||| S:18822 E:18827 ||| NN
.  ||| S:18827 E:18851 ||| .
Methods  ||| S:18851 E:18878 ||| FW
Cell  ||| S:18878 E:18883 ||| FW
culture  ||| S:18883 E:18891 ||| FW
conditions  ||| S:18891 E:18912 ||| FW
Suspended  ||| S:18912 E:18922 ||| FW
HL-60  ||| S:18922 E:18928 ||| FW
promyelocytic  ||| S:18928 E:18942 ||| FW
leukemia  ||| S:18942 E:18951 ||| FW
cells  ||| S:18951 E:18957 ||| NNS
were  ||| S:18957 E:18972 ||| VBD
cultured  ||| S:18972 E:18981 ||| VBN
in  ||| S:18981 E:18984 ||| IN
IMDM  ||| S:18984 E:18989 ||| NNP
( ||| S:18989 E:18990 ||| -LRB-
Clonetics ||| S:18990 E:18999 ||| NNP
)  ||| S:18999 E:19001 ||| -RRB-
supplemented  ||| S:19001 E:19014 ||| NN
with  ||| S:19014 E:19019 ||| IN
10 ||| S:19019 E:19021 ||| CD
%  ||| S:19021 E:19023 ||| NN
fetal  ||| S:19023 E:19039 ||| JJ
bovine  ||| S:19039 E:19046 ||| JJ
serum  ||| S:19046 E:19052 ||| NNS
( ||| S:19052 E:19053 ||| -LRB-
Hyclone ||| S:19053 E:19060 ||| NNP
) ||| S:19060 E:19061 ||| -RRB-
.  ||| S:19061 E:19063 ||| .
Cells  ||| S:19063 E:19069 ||| NNS
were  ||| S:19069 E:19074 ||| VBD
seeded  ||| S:19074 E:19081 ||| VBN
in  ||| S:19081 E:19084 ||| IN
tissue  ||| S:19084 E:19101 ||| NN
culture  ||| S:19101 E:19109 ||| NN
flasks  ||| S:19109 E:19116 ||| NN
at  ||| S:19116 E:19119 ||| IN
a  ||| S:19119 E:19121 ||| DT
density  ||| S:19121 E:19129 ||| NN
of  ||| S:19129 E:19132 ||| IN
3  ||| S:19132 E:19134 ||| CD
×  ||| S:19134 E:19136 ||| CD
10  ||| S:19136 E:19139 ||| CD
5cells ||| S:19139 E:19145 ||| CD
/ ||| S:19145 E:19146 ||| CD
ml  ||| S:19146 E:19149 ||| NNS
and  ||| S:19149 E:19163 ||| CC
expanded  ||| S:19163 E:19172 ||| VBN
when  ||| S:19172 E:19177 ||| WRB
the  ||| S:19177 E:19181 ||| DT
culture  ||| S:19181 E:19189 ||| NN
reached  ||| S:19189 E:19197 ||| VBD
3  ||| S:19197 E:19199 ||| CD
×  ||| S:19199 E:19201 ||| CD
10  ||| S:19201 E:19204 ||| CD
6cells ||| S:19204 E:19210 ||| CD
/ ||| S:19210 E:19211 ||| CD
ml ||| S:19211 E:19213 ||| NNS
.  ||| S:19213 E:19215 ||| .
To  ||| S:19215 E:19228 ||| TO
induce  ||| S:19228 E:19235 ||| VB
macrophage  ||| S:19235 E:19246 ||| JJ
differentiation ||| S:19246 E:19261 ||| NN
,  ||| S:19261 E:19263 ||| ,
10  ||| S:19263 E:19266 ||| CD
nM  ||| S:19266 E:19269 ||| JJ
phorbol  ||| S:19269 E:19277 ||| JJ
ester  ||| S:19277 E:19293 ||| NNS
( ||| S:19293 E:19294 ||| -LRB-
TPA ||| S:19294 E:19297 ||| NNP
)  ||| S:19297 E:19299 ||| -RRB-
was  ||| S:19299 E:19303 ||| VBD
added  ||| S:19303 E:19309 ||| VBN
to  ||| S:19309 E:19312 ||| TO
growth  ||| S:19312 E:19319 ||| NN
cultures  ||| S:19319 E:19328 ||| NNS
at  ||| S:19328 E:19331 ||| IN
a  ||| S:19331 E:19333 ||| DT
cell  ||| S:19333 E:19338 ||| NN
density  ||| S:19338 E:19346 ||| NN
of  ||| S:19346 E:19359 ||| IN
1.5  ||| S:19359 E:19363 ||| CD
×  ||| S:19363 E:19365 ||| CD
10  ||| S:19365 E:19368 ||| CD
6cells ||| S:19368 E:19374 ||| CD
/ ||| S:19374 E:19375 ||| CD
ml ||| S:19375 E:19377 ||| NN
,  ||| S:19377 E:19379 ||| ,
40  ||| S:19379 E:19382 ||| CD
hrs  ||| S:19382 E:19386 ||| NNS
prior  ||| S:19386 E:19392 ||| RB
to  ||| S:19392 E:19395 ||| TO
harvest ||| S:19395 E:19402 ||| NN
.  ||| S:19402 E:19404 ||| .
To  ||| S:19404 E:19417 ||| TO
depolymerize  ||| S:19417 E:19430 ||| VB
actin  ||| S:19430 E:19436 ||| JJ
microfilaments ||| S:19436 E:19450 ||| NN
,  ||| S:19450 E:19452 ||| ,
cells  ||| S:19452 E:19458 ||| NNS
were  ||| S:19458 E:19463 ||| VBD
treated  ||| S:19463 E:19481 ||| VBN
with  ||| S:19481 E:19486 ||| IN
0.1  ||| S:19486 E:19490 ||| CD
μg ||| S:19490 E:19492 ||| FW
/ ||| S:19492 E:19493 ||| FW
ml  ||| S:19493 E:19496 ||| FW
latrunculin  ||| S:19496 E:19508 ||| FW
B  ||| S:19508 E:19510 ||| NNP
( ||| S:19510 E:19511 ||| -LRB-
Cytoskeleton ||| S:19511 E:19523 ||| NNP
,  ||| S:19523 E:19525 ||| ,
Inc. ||| S:19525 E:19529 ||| NNP
)  ||| S:19529 E:19531 ||| -RRB-
30  ||| S:19531 E:19534 ||| CD
min  ||| S:19534 E:19548 ||| NNS
prior  ||| S:19548 E:19554 ||| RB
to  ||| S:19554 E:19557 ||| TO
harvest ||| S:19557 E:19564 ||| NN
.  ||| S:19564 E:19594 ||| .
Cell  ||| S:19594 E:19599 ||| NN
harvest  ||| S:19599 E:19607 ||| NN
and  ||| S:19607 E:19611 ||| CC
serial  ||| S:19611 E:19618 ||| JJ
extraction  ||| S:19618 E:19639 ||| JJ
Subcellular  ||| S:19639 E:19651 ||| JJ
fractionation  ||| S:19651 E:19665 ||| NN
of  ||| S:19665 E:19668 ||| IN
RNA  ||| S:19668 E:19672 ||| NNP
into  ||| S:19672 E:19687 ||| IN
cytoskeleton-associated  ||| S:19687 E:19711 ||| JJ
and  ||| S:19711 E:19715 ||| CC
cytosolic  ||| S:19715 E:19725 ||| JJ
fractions  ||| S:19725 E:19735 ||| NNS
was  ||| S:19735 E:19749 ||| VBD
performed  ||| S:19749 E:19759 ||| VBN
as  ||| S:19759 E:19762 ||| IN
previously  ||| S:19762 E:19773 ||| RB
described  ||| S:19773 E:19783 ||| VBN
[  ||| S:19783 E:19785 ||| -LRB-
15  ||| S:19785 E:19788 ||| CD
34  ||| S:19788 E:19791 ||| CD
]  ||| S:19791 E:19793 ||| -RRB-
.  ||| S:19793 E:19795 ||| .
In  ||| S:19795 E:19798 ||| IN
brief ||| S:19798 E:19803 ||| JJ
,  ||| S:19803 E:19815 ||| ,
HL-60  ||| S:19815 E:19821 ||| CD
cells  ||| S:19821 E:19827 ||| NNS
were  ||| S:19827 E:19832 ||| VBD
harvested  ||| S:19832 E:19842 ||| VBN
by  ||| S:19842 E:19845 ||| IN
centrifugation  ||| S:19845 E:19860 ||| NN
and  ||| S:19860 E:19874 ||| CC
resuspension  ||| S:19874 E:19887 ||| NN
in  ||| S:19887 E:19890 ||| IN
buffer  ||| S:19890 E:19897 ||| VBG
A  ||| S:19897 E:19899 ||| DT
( ||| S:19899 E:19900 ||| -LRB-
10  ||| S:19900 E:19903 ||| CD
mM  ||| S:19903 E:19906 ||| JJ
Tris  ||| S:19906 E:19911 ||| NNP
pH  ||| S:19911 E:19914 ||| NNP
7.6 ||| S:19914 E:19917 ||| CD
,  ||| S:19917 E:19919 ||| ,
0.25  ||| S:19919 E:19924 ||| CD
M  ||| S:19924 E:19936 ||| NNP
sucrose ||| S:19936 E:19943 ||| NN
,  ||| S:19943 E:19945 ||| ,
25  ||| S:19945 E:19948 ||| CD
mM  ||| S:19948 E:19951 ||| JJ
KCl ||| S:19951 E:19954 ||| NN
,  ||| S:19954 E:19956 ||| ,
5  ||| S:19956 E:19958 ||| CD
mM  ||| S:19958 E:19961 ||| JJ
MgCl  ||| S:19961 E:19977 ||| JJ
2  ||| S:19977 E:19979 ||| CD
)  ||| S:19979 E:19981 ||| -RRB-
with  ||| S:19981 E:19986 ||| IN
0.1 ||| S:19986 E:19989 ||| CD
%  ||| S:19989 E:19991 ||| NN
Igepal  ||| S:19991 E:19998 ||| FW
nonionic  ||| S:19998 E:20017 ||| FW
detergent  ||| S:20017 E:20027 ||| FW
( ||| S:20027 E:20028 ||| -LRB-
Sigma ||| S:20028 E:20033 ||| NNP
) ||| S:20033 E:20034 ||| -RRB-
.  ||| S:20034 E:20036 ||| .
The  ||| S:20036 E:20040 ||| DT
minimal  ||| S:20040 E:20048 ||| JJ
concentration  ||| S:20048 E:20062 ||| NN
of  ||| S:20062 E:20065 ||| IN
nonionic  ||| S:20065 E:20084 ||| JJ
detergent  ||| S:20084 E:20094 ||| NN
required  ||| S:20094 E:20103 ||| VBN
to  ||| S:20103 E:20106 ||| TO
release  ||| S:20106 E:20114 ||| VB
cytosolic  ||| S:20114 E:20124 ||| JJ
components  ||| S:20124 E:20145 ||| NNS
without  ||| S:20145 E:20153 ||| IN
disrupting  ||| S:20153 E:20164 ||| JJ
nuclei  ||| S:20164 E:20171 ||| NN
was  ||| S:20171 E:20175 ||| VBD
determined  ||| S:20175 E:20186 ||| VBN
by  ||| S:20186 E:20189 ||| IN
measuring  ||| S:20189 E:20209 ||| VBG
lactate  ||| S:20209 E:20217 ||| JJ
dehydrogenase  ||| S:20217 E:20231 ||| JJ
activity  ||| S:20231 E:20240 ||| NN
as  ||| S:20240 E:20243 ||| IN
a  ||| S:20243 E:20245 ||| DT
marker  ||| S:20245 E:20252 ||| NN
for  ||| S:20252 E:20256 ||| IN
release  ||| S:20256 E:20264 ||| NN
of  ||| S:20264 E:20277 ||| IN
cytosol ||| S:20277 E:20284 ||| NN
.  ||| S:20284 E:20286 ||| .
The  ||| S:20286 E:20290 ||| DT
detergent  ||| S:20290 E:20300 ||| NN
concentration  ||| S:20300 E:20314 ||| NN
that  ||| S:20314 E:20319 ||| WDT
released  ||| S:20319 E:20331 ||| VBD
